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The designed ‘‘ATCUN’’ motif (amino-terminal copper and nickel binding site) is a
replica of naturally occurring ATCUN site found in many proteins/peptides, and
an attractive platform for multiple applications, which include nucleases, prote-
ases, spectroscopic probes, imaging, and small molecule activation. ATCUN
motifs are engineered at periphery by conjugation to recombinant proteins,
peptides, fluorophores, or recognition domains through chemically or geneti-
cally, fulfilling the needs of various biological relevance and a wide range of
practical usages. This chemistry has witnessed significant growth over the last
few decades and several interesting ATCUN derivatives have been described.
The redox role of the ATCUN moieties is also an important aspect to be consid-
ered. The redox potential of designed M-ATCUN derivatives is modulated by
judicious choice of amino acid (including stereochemistry, charge, and position)
that ultimately leads to the catalytic efficiency. In this context, a wide range of
M-ATCUN derivatives have been designed purposefully for various redox- and
non-redox-based applications, including spectroscopic probes, target-based cat-
alytic metallodrugs, inhibition of amyloid-b toxicity, and telomere shortening,
enzyme inactivation, biomolecules stitching or modification, next-generation
antibiotic, and small molecule activation.
INTRODUCTION
Over the last few decades, the research on designed metal-ATCUN derivatives (ATCUN; amino terminal
copper and nickel binding motif possessing H2N–X-X-His sequence; X = any amino acid) has greatly pro-
gressed due to the wide range of applications envisaged, relevant for biology and chemistry, which include
DNA (Harford and Sarkar, 1997; Mack and Dervan, 1992; Jin and Cowan, 2005, 2007; Agbale et al., 2016; Yu
and Cowan, 2017a, 2017b; Gonzalez et al., 2018), RNA (Yu and Cowan, 2017a, 2017b; Gonzalez et al., 2018;
Ross et al., 2017), proteins (Agbale et al., 2016; Yu and Cowan, 2017a, 2017b; Gonzalez et al., 2018; Pinkham
et al., 2018a, 2018b), sugar (Yu and Cowan, 2017a, 2017b), and lipids cleavage (Alexander et al., 2017), anti-
tumor (Kimoto et al., 1983), and antimicrobial activity (Alexander et al., 2018, 2019), inhibition of enzyme
activity (Gokhale et al., 2008), telomere shortening (Yu et al., 2015), and aggregation of amyloid-b peptides
(Zhang et al., 2016), nitration of tyrosine (Maiti et al., 2019), protein-protein cross-linking (Horowitz et al.,
2012; Brown et al., 1998), water oxidation (Deng et al., 2018), hydrogen evolution (Kandemir et al., 2016),
nitrite to NH3 (Guo et al., 2018), useful in spectroscopic probes (Donaldson et al., 2001; Maiti et al.,
2017b; Deng et al., 2019a, 2019b; Torrado et al., 1998), and imaging (Miyamoto et al., 2016).
The storyline started in 1960s, when ATCUN motif was first found in human serum albumin (HSA) (Harford
and Sarkar, 1997; Laussac and Sarkar, 1984). Since then, it was found in a large number of other naturally
occurring proteins/peptides, including BSA (Harford and Sarkar, 1997; Laussac and Sarkar, 1984), hepcidin
(Fleming and Sly, 2001), neuromedins C and K (Harford and Sarkar, 1995), human sperm protamine P2a
(Mckay et al., 1986), and histatins (Conklin et al., 2017). During this period, the understanding of structure
and function of this metal binding ATCUNmotif in proteins and peptides was intensively investigated (Har-
ford and Sarkar, 1997; Mack and Dervan, 1992; Jin and Cowan, 2005, 2007; Agbale et al., 2016; Yu and
Cowan, 2017a, 2017b; Gonzalez et al., 2018; Alexander et al., 2018, 2019). The structure of ATCUN motif
in albumin is well characterized, and its primary function is assigned to the Cu-transport in blood (Harford
and Sarkar, 1997; Laussac and Sarkar, 1984). Therefore, the design of ATCUN motif is of interest foriScience 23, 101792, December 18, 2020





Reviewmimicking the structure and function of naturally occurring proteins and peptides, as well as for other new
performances. Many efforts are being made in designing ATCUNmotifs with amino acid variants, as well as
its conjugation with protein, peptide, or fluorophore for fulfilling the needs of various practical and biolog-
ical relevant usages (Gonzalez et al., 2018; Pinkham et al., 2018a, 2018b; Donaldson et al., 2001; Maiti et al.,
2017a; Deng et al., 2019a, 2019b; Torrado et al., 1998; Miyamoto et al., 2016). The designed parameters
include stereochemistry, position, and charge of amino acid, modulating the redox potential of the metal
center inM-ATCUNderivatives (M =CuII, NiII, and CoII), leading to catalytic efficiency (Jin and Cowan, 2005,
2007).
In this context, a wide range of applications of M-ATCUN derivatives can be classified into two classes:
redox- and non-redox-based applications. However, Cu-ATCUN and Ni-ATCUN derivatives (little informa-
tion has been so far reported on Co-ATCUN) are mostly introduced for cleavage or modification of biomol-
ecules (such as DNA, RNA, proteins, and amino acids) that are catalyzed by a redox-dependent mechanism
(Harford and Sarkar, 1997; Mack and Dervan, 1992; Jin and Cowan, 2005, 2007; Agbale et al., 2016; Yu and
Cowan, 2017a, 2017b; Gonzalez et al., 2018). The cleavage of biomolecules by M-ATCUN derivatives is not
a random process. This chemistry is designed intentionally, where catalytic center (M-ATCUN) is coupled
with the target domain to yield a cocktail complex that selectively binds and oxidatively modifies the ther-
apeutically relevant biomolecules (Yu and Cowan, 2017a, 2017b; Gonzalez et al., 2018; Yu et al., 2015; Joy-
ner and Cowan, 2011). In addition, M-ATCUN derivatives also perform a variety of small molecule activation
processes (Deng et al., 2018; Kandemir et al., 2016; Guo et al., 2018).
On the other hand, ATCUN motifs stabilized in a particular oxidation state of metal ion, specially CuII-
ATCUN derivatives, are considered as a useful spectroscopic probes such as paramagnetic nuclear mag-
netic resonance (NMR) (Maiti et al., 2017b), sensor (Torrado et al., 1998), and imaging (Miyamoto et al.,
2016). Due to high stability of CuII-ATCUN complex, the ATCUN motif can be used as a Cu-chelation ther-
apy, such as inhibition of aggregation of amyloid-b peptides (Zhang et al., 2016). The combination of AT-
CUN motif with selected recombinant proteins, peptides, or fluorophores are also used in order to under-
stand the structure and function of biomolecules (Donaldson et al., 2001; Maiti et al., 2017b; Deng et al.,
2019a, 2019b; Torrado et al., 1998; Miyamoto et al., 2016).
Over the decades, designed M-ATCUN derivatives rely on various redox- and non-redox-based applica-
tions, especially spectroscopic probes, target-based catalytic metallodrugs, inhibition of amyloid-b toxicity
and telomerase activity, biomolecules stitching or modification, next-generation antibiotic and small mol-
ecules activation. With such a wide range of applications, it is clear that interest in the ATCUNmotif is likely
to expand in various field in the coming years. Review highlights on the rational design, redox chemistry,
and applications of M-ATCUN derivatives in different fields, and viewpoint on this emerging field.
BIOLOGICAL ROLE OF M-ATCUN MOTIF IN PROTEINS/PEPTIDES
The metal-binding ATCUN motif is present in many natural proteins and peptides, which plays a funda-
mental role in metal homeostasis under physiological conditions (Harford and Sarkar, 1997; Laussac and
Sarkar, 1984; Fleming and Sly, 2001). HSA is one of the most important copper transport proteins in blood,
known as labile Cu pool in extracellular space, and ensures copper homeostasis in human body by utilizing
the ATCUN tag (Harford and Sarkar, 1997; Laussac and Sarkar, 1984). Otherwise, dysregulation of Cu ho-
meostasis leads to several number of human diseases, which are WD, cancer, diabetes, and Alzheimer’s
disease (AD) (Lowe et al., 2017; Maiti and Moura, 2020). Histamin is one class of natural host defense pep-
tide, possessing ATCUN site that involves in antimicrobial activity (Conklin et al., 2017). Hepcidin-25, an
iron-regulatory hormone containing ATCUN site, is responsible for iron homeostasis in mammals (Fleming
and Sly, 2001). Another class of peptides with ATCUN site, neuromedin C, a neurotransmitter, acts as a
growth factor for some tumors and also plays a key role in metal homeostasis in the central nervous system
(Harford and Sarkar, 1995). Therefore, these findings provide inspiration to design synthetic ATCUN deriv-
atives with useful metal-binding properties as well as reactivity.
DESIGN OF ATCUN DERIVATIVES
Artificial ATCUN motifs have been devoted considerable attention ever since its discovery in HSA.1
Decades of investigations have been put forward several interesting ATCUN derivatives, which have
been designed purposefully in order to understand the stability, redox chemistry, efficacy, and selectivity.
The basic design strategies of ATCUN derivatives are introduction of variable amino acid (X) at first and2 iScience 23, 101792, December 18, 2020
Figure 1. Schematic Representation of Design Strategies of Synthesized ATCUN and Its Metal Derivatives
R1 and R2; variable amino acids at first and second positions in NH2-R




Reviewsecond positions in NH2-X-X-His sequence and/or conjugation of ATCUN motif with protein, peptide, or
fluorophore (Figure 1). The initial design of ATCUN motif was interested from NH2-terminal protein se-
quences of albumins (Harford and Sarkar, 1997; Sankararamakrishnan et al., 2005; Lau et al., 1974), and anti-
microbial peptides (AMPs) (Alexander et al., 2018, 2019). Variable side chains of amino acids surrounding
His residue in ATCUN site significantly influence the activity and metal binding affinity, but they do not
directly involve in metal coordination. This design is of interest, specifically, for catalytic activities like
DNA, RNA, protein cleavage/modification as described below (Harford and Sarkar, 1997; Mack and Der-
van, 1992; Jin and Cowan, 2005, 2007; Agbale et al., 2016; Yu and Cowan, 2017a, 2017b; Gonzalez et al.,
2018).
A series of ATCUNmotifs are synthesized by introduction of various amino acid residues at first and second
positions of ATCUN, such as case-I: simplest amino acid (Gly), case-II: hydrophobic and aromatic amino
acids (Phe and Tyr); case-III: hydrophilic and neutral amino acids (such as; Asn and Thr), case-IV hydrophilic
and negatively charged amino acid (Val, Asp), case-V: hydrophilic and positively charged amino acids (Arg
and Lys) and case-VI: L-to D-amino acid (Jin and Cowan, 2005, 2007; Miyamoto et al., 2016; Kozłowski et al.,
1999; Sóvágó and Osza, 2006; Sóvágó et al., 2016; Bal et al., 1996). Generally, these simple and small pep-
tides based ATCUN derivatives are synthesized by a conventional solid-phase peptide synthesis method
employing the Fmoc strategy (Neupane et al., 2013).
Dervan et al. first designed ATCUN motif possessing GGH sequence that was the simplest replica of natu-
rally occurring ATCUNmotif in proteins or peptides (Mack and Dervan, 1990, 1992; Mack et al., 1988). In this
regard, varieties of ATCUN derivatives have been designed. For example, the positively charged amino
acid, like lysine (K) and arginine (R) at positions 1 and 2 in ATCUN motif enhances the CuII binding affinity,




Reviewaffinity (Kozłowski et al., 1999). Moreover, the bulkiness and hydrophobic side chain of amino acid residues
at first and second positions may increase the stability of Cu-ATCUN derivatives (Kozłowski et al., 1999; Bal
et al., 1996; Sokolowska et al., 2002; Pettit et al., 1990). The stability of the various synthetic CuII-ATCUN
derivatives is tested under aqueous solution, blood plasma, and living animals (Miyamoto et al., 2016).
In aqueous solution, the stability of CuII-ATCUN derivatives is influenced by basicity of side chain at first
and second positions, as the result of the competition between the protonation and the CuII coordination
of the 4N ligands. In plasma, the stability of the 64CuII–ATCUN derivatives is significantly increased by intro-
duction of bulky and hydrophobic side chain of amino acid at first and second positions (Kozłowski et al.,
1999; Camerman et al., 1976). In addition, incorporation of D-amino acid instead of L-amino acid elevates
the stability and reactivity of ATCUN motif significantly (Jin and Cowan, 2005, 2007).
The above designed ATCUN derivatives are also conjugated with small organic molecules at positions 1, 2,
3 and NH2- (in N-terminus site) with or without a linker moiety. This designed has been, particularly, devel-
oped as a sensor (Yu and Cowan, 2017a, 2017b; Gonzalez et al., 2018; Torrado et al., 1998; Wendea and
Kulak, 2015; Libardo et al., 2014). Torrado et al. have designed three ATCUN-organic derivatives where
organic molecule, 5-(dimethylamino)naphthalene-1-sulfonamide (Dns), as a fluorophore has been incorpo-
rated into NH2-GGH at NH2- site with a linker (-CH2-, -C2H4- and -C3H6-) (Torrado et al., 1998). Several
ATCUN-dns derivatives are reported where Dns group is attached to the vicinity of the ATCUN motif at
any amino acid residue (at position, 1, 2, or 3) in ATCUN (Zheng et al., 2002; Choi et al., 2015).
Another strategy is the conjugation of ATCUN motif with protein and/or peptide that is generally synthe-
sized genetically. Usually, a DNA fragment-encoded ATCUN coupled with protein or peptide sequence is
amplified by polymerization chain reaction. Afterward, it is ligated into the vector for ATCUN-protein or
-peptide expression. ATCUN-fusion proteins or peptides are generally obtained from heterologous over-
expression in E. coli (Donaldson et al., 2001; Choi et al., 2015; Pauleta et al., 2007). Mack et al. successfully
introduced artificial ATCUN tag into NH2-terminus of the DNA binding Hin recombinase protein geneti-
cally (Mack and Dervan, 1990). Based on this concept, several hybrid ATCUN-protein (or peptides) deriv-
atives are reported, which include multi-domain human ubiquitin protein (Donaldson et al., 2001), orange
protein (ORP) (Maiti et al., 2017b), green fluorescent protein (GFP) (Choi et al., 2015), and AMPs (Alexander
et al., 2018). In addition, the redox catalytic M-ATCUN domain is linked with a gene-specific recognition
domain (peptide or substrate) that selectively targets the disease-associated gene, like DNA, RNA, and
protein, leading to oxidative damage/modification.
Over the last few decades, the designed strategies have been implicated as a potential catalytic metallo-
drug toward nucleases and proteins inactivation as described below. The stability of M-ATCUN derivatives,
in vivo, is also a key factor for clinical diagnosis because it must reach to target site with its active form (Mjos
and Orvig, 2014). Overall, design of ATCUN derivative has been developed for wide applicability either as
spectroscopic probe or as catalytic machine for nucleases, modification of biomolecules, and small mole-
cule activation.INTERACTION OF ATCUN MOTIF WITH METAL IONS
The ATCUNmotif, a promising metal binding scaffold, binds with metal ions in a specific manner, defining
four nitrogens (terminal amine, two intervening peptide bond nitrogen atoms and the histidine N3 nitro-
gen) coordinated square planar complexes. It is common to know that ATCUN motif interacts mainly
CuII and NiII ions. In fact, it can interact with many metal ions, and this interaction depends on the metal
ions, deprotonation of the amide groups, and coordination of histidine nitrogen (Burger, 1990). Deproto-
nation of amide nitrogen in aqueous medium requires strongly basic conditions (pKa z15) in the absence
of metal ion. But the process is significantly enhanced in the presence of metal ions, when the imidazole
ring of the histidine residue is available to act as an anchor for the metal ion (Bortolus et al., 2010; Sundberg
and Martin, 1974). Only few metal ions are able to induce the deprotonation of CONH groups, forming
M-ATCUN species at physiological pH. Among them, CuII and NiII-ATCUN are formed at physiological
pH, but CoII-ATCUN is formed at slightly higher pH (9) (Neupane et al., 2013; Hawkins and Martin,
1983). ATCUN motifs have been also shown to bind other metal ions, which are AuIII, PtII, and PdII at
very low pH (1–2) to form square planar complexes as Ni-, Cu-ATCUN complexes (Best et al., 1997; Kirvan
and Margerum, 1985; Lihi et al., 2017). These findings provide a useful information for the synthesis of new
M-ATCUN derivatives.4 iScience 23, 101792, December 18, 2020







Affinity (K in M1)
HAS (Gonzalez et al., 2018; Rozga et al., 2007) DAH 12.0 1.0 x 1012
BSA (Rozga et al., 2007) DTH 12.0 1.0 x 1012
Hepcidin N-term (Płonka and Bal, 2017) DTH 14.7 5.0 x 1014
des-angiotensinogen N-term
(Sokolowska et al., 2002)
VIH 13.0 1.0 x 1013
Human copper transporter (hCTR1-14aa)
(Bossak et al., 2018)
MDH 11.0 1.0 3 1011
Ab4-16 (Mital et al., 2015) RFH 13.5 3.2 x 10
13
HP2 N-term (Bal et al., 1997) RTH 14.5 3.2 x 1014
Endostain N-term (Kolozsi et al., 2009) HSH 14.5 3.2 x 1014
GGH-COOH (Hay et al., 1993) GGH 12.4 2.5 x 1012
DAHK-NH2 (Rozga et al., 2007) DAH 13.8 6.3 x 10
13
YYH-COOH (Miyamoto et al., 2016) YYH 14.4 2.5 x 1014
MDH-NH2 (Bossak et al., 2018) MDH 13.1 1.3 3 10
13
MNH-NH2 (Bossak et al., 2018) MNH 14.5 3.2 3 10
14




ReviewSince HSA is known as the first source of ATCUN motif and participates in the CuII transport in blood (Har-
ford and Sarkar, 1997; Laussac and Sarkar, 1984; Carter and Ho, 1994), the understanding of metal-albumin
interaction is necessary to be considered in this respect. HSA possesses two specific CuII binding sites,
ATCUN site, and the multimetal binding site (MBS), in which CuII binds strongly with ATCUN site over
MBS (Bal et al., 2013; Al-Harthi et al., 2019). ATCUN motif in albumin not only interacts CuII or NiII, but
also interacts other metal ions, which are ZnII, VIVO, and CdII (Bal et al., 2013). Based on competition studies,
VIVO prefers ATCUN site, while ZnII or CdII prefers MBS (Al-Harthi et al., 2019).
The stability constant of Cu-ATCUN in HSA and other proteins/peptides is in range, 12 < log cK7.4 < 15,
depending on surrounding amino acid residues of ATCUN (Gonzalez et al., 2018; Rozga et al., 2007). In
addition, ATCUN motif shows higher selectivity for CuII binding over other physiological cations because
CuII may has strong lewis acid character and preferes square-planar geometry. In general, the binding af-
finity of the ATCUNmotif for CuII is higher (about six order of magnitude) than for NiII.65 The binding affinity
of some synthetic as well as naturally occuring ATCUNs are tabulated in Table 1 (Gonzalez et al., 2018;
Rozga et al., 2007).
REDOX CHEMISTRY OF M-ATCUN DERIVATIVES
The redox chemistry of M-ATCUN derivatives is a useful index due to its wide variety of catalytic activities.
So, intense interests in electrochemical studies on M-ATCUN derivatives are described in literature (Gon-
zalez et al., 2018; Neupane et al., 2013; Mital et al., 2015; Hureau et al., 2011; Wiloch et al., 2017). The redox
potential of Mn+/M(n1)+ in M-ATCUN derivatives highly depends on the nature of amino acid at periphery
of ATCUN motif and geometry of metal-complexes. For instance, copper exhibits mainly two accessible
redox couples, CuII/CuI and CuIII/CuII in various catalytic activities. The CuII/CuI is more available in biolog-
ical system over CuIII/CuII redox couple (Solomon et al., 2014). The inherent problem between CuI and CuII
is in coordination chemistry (Solomon et al., 2014; Maiti et al., 2018). For instance, CuII (CuIII also) adopts a
square planar geometry, but CuI cannot adopt the same geometry as CuII and it prefers tetrahedral or tri-,
bi-coordinated geometry (Solomon et al., 2014; Maiti et al., 2018). Thus, CuII/CuI redox couple is highly
geometric reorganization, resulting less efficient in redox chemistry, whereas the CuIII/CuII redox couple
involves low reorganization energy, resulting more efficient in redox chemistry. In Cu-ATCUN derivatives,
the key point is the CuII/CuI redox couple, where CuI cannot bind at the same coordination site as CuII.iScience 23, 101792, December 18, 2020 5
Cu-ATCUNa E = CuIII/CuII (DE = Relative
to CuII-GGH-CONH2)
(mV vs. NHE)
Ni-ATCUNa E = NiIII/NiII (DE = Relative
to NiII-GGH-CONH2)
(mV vs. NHE)
CuII-GGH-CONH2 1068 (00) NiII-GGH-CONH2 1087 (00)
CuII-GKH-CONH2 1057 (11) NiII-GKH-CONH2 1097 (10)
CuII-KGH-CONH2 1051 (17) NiII-KGH-CONH2 1097 (10)
CuII-KKH-CONH2 1017 (51) NiII-KKH-CONH2 1077 (10)
CuII-KGHK-CONH2 1049 (19) NiII-KGHK-CONH2 1067 (20)
CuII-GkH-CONH2 1032 (36) NiII-GkH-CONH2 1157 (18)
CuII-kGH-CONH2 1033 (35) NiII-kGH-CONH2 1067 (20)
CuII-kkH-CONH2 993 (69) NiII-kkH-CONH2 1047 (40)
CuII-GGH-COOH 1034 (34) NiII-GGH-COOH 1007 (80)
Table 2. Redox Potential of CuII-ATCUN and NiII-ATCUN Derivatives




ReviewThe Ni-ATCUN analogs, generally, involve NiII/NiIII redox couple in their potential catalytic applications.
The transformation from NiII (Sq. planar) to NiIII (sq. pyramid) involves geometry organization accompa-
nying large gain in ligand field stabilization energy with respect to CuII/CuIII redox couple in Cu-ATCUN
system (Bossu et al., 1977). The other analog, Co-ATCUN derivative, generally, shows CoII/CoIII redox
couple in their redox chemistry without geometry organization (both are sq. planar geometry). Such elec-
trochemical studies are performed on variety of designed linear and cyclic ATCUN motifs (Jin and Cowan,
2005, 2007; Neupane et al., 2013, 2014; Mital et al., 2015; Hureau et al., 2011). The redox chemistry of
M-ATCUN derivative is influenced by several factors, such as geometry, stability of MIII center, variable
amino acid, positioning of amino acid in ATCUN motif, and stereochemical orientation of amino acid res-
idues relative to the M-ATCUN equatorial plane.
In this regard, Cowan et al. extensively studied on electrochemistry of a series of designed linear M-ATCUN
derivatives (Table 2) (Jin and Cowan, 2007). Both Cu- and Ni-ATCUN derivatives show decrease in their
redox potential with an increasing number of Lys residues in motif that influence the enhancement of
s-donor character relative to that of Gly on the stabilization of the MIII center (Jin and Cowan, 2007).
The redox potential is also influenced by the position of Lys in ATCUN derivatives. At first position, Lys res-
idue has been greatly extended to stabilize the CuIII oxidation state than second position. The Lys residue
at fourth position in Cu-GGHK, does not influence the CuIII/II redox potential as seen in Cu-KGH derivative
because backbone amide of fourth position Lys does not directly bind to Cu center. In Ni-KGHK derivative,
the side chain amine groups of Lys residues (at second and fourth positions) interact at the axial site of NiIII
center, leading to more stabilization of NiIII. Similarly, incorporation of two Lys at first and second positions
in Ni-KKH sequence, the NiIII is effectively stabilized relative to the first or second position alone (Bossu
et al., 1977; Murray and Margerum, 1982). So, stabilization of CuIII and NiIII in ATCUN derivatives depends
not only on electrostatic interaction but also on the spatial orientation of the amino acid residues. In addi-
tion, the redox potential of CuIII/II-GGH-COOH is increased to 34 mV upon amidation at remote C-termi-
nal COOH. Similar trend is observed in redox potential of NiIII/II-GGH-CONH2 (80 mV with respect to free
carboxylate in GGH-COOH) (Jin and Cowan, 2007). Further study with other derivative, KGHK-COOH,
upon amidation of the more remote C-terminus, the redox potential is noticeable increased to 0.9 mV
for CuIII/II-KGHK and 20 mV for NiIII-KGHK. The switching from L- to D-Lys, the CuIII is more stabilized,
due to specific spatial orientation of D-Lys that leads to more negative redox potential corresponding
to L-Lys isomers of Cu-ATCUN derivatives (Table 2). This redox effect is also observed in D-isomer,
NiIII-kkH, but it is significantly lower extent to redox potential (Jin and Cowan, 2007).
Dervan and coworkers first showed that designed GGHG-Hin-recombinase derivative performed DNA
cleavage oxidatively (Mack et al., 1988). Therefore, Cu-GGHG derivative is of considerable interest for




Reviewthe redox potential at 978 mV vs. NHE, which is very close to CuII-GGH-COOH system (1003 mV vs. NHE)
(McDonald et al., 1997). Another important naturally occurring ATCUN sequence, DAHK is found in the
blood plasma, HSA (Hureau et al., 2011; Sendzik et al., 2017). The CV trace of designed CuII-DAHK deriv-
ative shows a reversible peak at E1/2 = 0.77 V (vs. AgCl/Ag) corresponding to the Cu
III/CuII redox couple,
but no reduction redox couple, CuII/CuI is observed (Hureau et al., 2011; Guilloreau et al., 2007). Therefore,
the reduction of CuII to CuI in model peptide, CuII-DAHK is difficult by ascorbate, but it is relatively easier in
HSA (Hureau et al., 2011). This unusual redox behavior of Cu-DAHK in serum albumin is assigned to the
presence of two close proximity His residues near-by ATCUN motif that facilitates the reduction of CuII
to CuI by ascorbate and stabilize it after reduction via His-CuI-His coordination (Haas et al., 2011;Wezynfeld
et al., 2016; Hureau, 2012). The bis-His motif has higher magnitude for CuI binding over ATCUN motif
(Zheng et al., 2002; Płonka and Bal, 2017). Therefore, ATCUN motif and near by bis-His motif both signif-
icantly play the redox interconversion between CuII and CuI (Haas et al., 2011; Wezynfeld et al., 2016; Hur-
eau, 2012).
The redox chemistry is also examined in a series of designed cyclic and linear M-ATCUN derivatives (Neu-
pane et al., 2013). Joshua Kritzer et al. reported a nice work on redox chemistry of cyclic and linear ATCUN
derivatives, including effects of macrocyclization (Neupane et al., 2013). The copper bound cyclic- and
linear-ATCUN derivatives show quasi-reversible peak with almost the same reduction potential value of
CuIII/CuII redox couple (740–810 mV vs. SCE) and no reduction couple, CuII/CuI is observed. In addition,
the cyclic Cu-ATCUN derivatives enhance the CuIII/CuII redox cycling (facilitates electron transfer) than
linear Cu-ATCUN derivatives (Neupane et al., 2013).
Like Cu- and Ni-ATCUN, Co-ATCUN analogs, including Co-GGH and Co-KGHK derivatives show the redox
interplay mainly between CoIII and CoII, with relatively low redox potentials values at119 and228 mV vs.
NHE, respectively (Joyner and Cowan, 2011). This result also supports that upon inclusion of positive
charge amino acid (Lys) in ATCUN site, the redox potential is decreased.PRODUCTION OF HYDROXYL RADICAL BY M-ATCUN DERIVATIVES
The understanding of mechanism and efficiency of hydroxyl radical formation by M-ATCUN are an impor-
tant task because the oxidative cleavage/modification of biomolecules are induced by the hydroxyl radical
(,OH) (see below). The formation of ,OH is directly associated with redox potential of M-ATCUN deriva-
tives (Jin and Cowan, 2007; Gokhale et al., 2008; Joyner et al., 2011; Fang et al., 2004). Therefore, the
,OH production ability of varieties Cu-ATCUN derivatives is examined in presence of H2O2 (oxidant)
and ascorbate (reductant) (Jin and Cowan, 2007; Neupane et al., 2013; Joyner and Cowan, 2011). Several
experimental observations conclude that the production of ,OH by Cu-ATCUN is more efficient in pres-
ence of H2O2/ascorbate system with respect to H2O2 or ascorbate alone (Jin and Cowan, 2007; Neupane
et al., 2013; Libardo et al., 2014; Joyner et al., 2011; Santoro et al., 2018). For instance, a series of tri-peptide
Cu-ATCUN derivatives (DAH, DMH, DSH, DTH, EAH, GGH, GKH, GNH, LKH, NGH, RTH, SMH, and VIH) are
designed for testing the ,OH production ability in presence of H2O2 and ascorbate. Among them, Cu–
GGH shows the highest rate (52.54 G 0.76 mM min1), whereas EAH shows the lowest rates (1.14 G
0.04 mM min1) of ,OH production in presence of H2O2/ascorbate (Asc
) system (Libardo et al., 2014).
The tri-peptide system is expanded to tetra-peptide, such as CuII-KGHK that has been also examined
for the production of ,OH in presence of Asc/H2O2 and the production rate of it is compared with Cu-
GGH. Both Cu-peptides derivatives show the higher rate of ascorbate consumption in presence of H2O2
(turn over number >100 for GGH and 44 G 7 for KGHK) than absence of H2O2 (turn over number 17 G 2
for GGH and 11 G 2 for KGHK) (Jin and Cowan, 2007; Joyner and Cowan, 2011).
Above results conclude that redox dependent mechanism of HO, formation by Cu-ATCUN derivatives is
involved in the variable oxidation states (I, II, and III) of copper. At neutral pH, the reduction potential of
H2O2/HO,, and ascorbyl radical/ascorbate are 380 mV (vs. NHE), and 66 mV (vs. NHE), respectively
(Wood 1988; Borsook and Keighley, 1933). Therefore, H2O2/ascorbate system plays the redox chemistry
with M-chelates complexes within +380 to 66 mV reduction potential window. In presence of ascorbate,
the generation of ,OHby CuII-ATCUN derivatives is proposed through a CuII/CuI reduction couple, but the
high reduction potential value of Cu-GGH (1038 mV vs. NHE) or Cu-KGHK (1058 mV vs. NHE) is incompat-
ible with reduction of CuII-ATCUN derivatives by ascorbate (Jin and Cowan, 2007; Santoro et al., 2018). In
this case, the key point is geometry reorganization in CuII/CuI redox couple, where CuI could not bind at the




ReviewCuI likely binds with biomolecules in vivo. This hypothesis is tested on CuII-KGHK, CuII-DAHK, or CuII-FRHD
derivatives in presence of CuI chelating agent, bathocuproinedisulfonate (BCS). Upon addition of ascor-
bate or H2O2, the formation of Cu
I-BCS2 complex is increased and consequently the production of ,OH
is decreased or completely seized (Santoro et al., 2018). This observation indicates that the formation of
CuI is directly connected with the formation of ,OH. Still, it has a space to improve the redox mechanism.
Similarly, Cu-analogs, including Ni-ATCUN and Co-ATCUN derivatives, are often studied for the produc-
tion of ,OH. Ni-ATCUN shows mainly one accessible redox couple, NiIII/NiII, which significantly generates
,OH in presence of H2O2/ascorbate system. Both Ni-GGH andNi-KGHK derivatives show the higher rate of
ascorbate consumption in presence of H2O2 (turn over number 40G 10 for GGH and 30G 8 for KGHK) than
absence of H2O2 (turn over number 9 G 2 for GGH and 9 G 2 for KGHK) (Jin and Cowan, 2007; Joyner and
Cowan, 2011). Unlike Ni- and Cu-ATCUN derivatives, both Co-GGH and Co-KGHK derivatives show the
same turn over number (>100) of ascorbate consumption, even in absence of H2O2, due to lower redox po-
tential of CoIII/CoII couple that facilitates ,OH production (Joyner and Cowan, 2011).APPLICATIONS OF M-ATCUN DERIVATIVES
In this context, a wide range of applications of M-ATCUN derivatives can be classified into two classes, – (1)
redox-based and (2) non-redox-based applications (Figure 2). M-ATCUN, especially, Cu-ATCUN shows a
redox silent component in presence of biological reductant, ascorbate due to its high redox potential
(ranging from 0.87 to 1.07 V vs. NHE)7 and inherent geometry problem between CuII and CuI, it make a
redox silent component in presence of biological reductant, ascorbate. Interestingly, Cu-ATCUN deriva-
tives have shown to ability the production of HO, under H2O2/AcsH
. Therefore, Cu-ATCUN derivatives
can be utilized for various applications into two ways: presence of H2O2/AcsH
 (redox active) and absence
of H2O2/AcsH
 (redox inactive). Based on literature survey, Cu/Ni-ATCUN derivatives are largely exploited
toward redox-based applications, whereas Co-ATCUN derivatives are limited. Same redox couple of cop-
per is more intensely used as a sensor probe in fluorescence turn-on/off switch. As a result, copper has
received a considerable amount of attention in this field. In this review, we focus on Cu-, Ni-, and Co-based
designed metal-ATCUN derivatives and their applications toward non-redox- and redox-based.Figure 2. Schematic Representations of Designed M-ATCUN Derivatives in Varous ApplicationsNon-Redox-Based Applications
The transition metal ions are extensively used for redox chemistry in a variety of chemical and biological
transformations, but their specific stable oxidation state has been also used as a potential spectroscopic
probe due to its inherent spectroscopic properties. Metal ions possessing observable spectroscopic fea-




Review(EPR), Mössbauer, fluorescence quencher and extended X-ray absorption fine structure in many metallo-
proteins (Maiti et al., 2017a; Hagen 2006; Holm et al., 1996). For example, CuII is a paramagnetic species
whereas CuI is a diamagnetic species. Based on this spectroscopic advantage, CuII-ATCUN state has
been studied extensively as a paramagnetic probes and sensors (Donaldson et al., 2001; Maiti et al.,
2017b; Deng et al., 2019a, 2019b; Torrado et al., 1998). Significantly, this review is mainly focused on stable
CuII-ATCUN derivatives as spectroscopic probe and positron emission tomography (PET) imaging (Miya-
moto et al., 2016). In addition, the ATCUN motif acts as a Cu-chelator for amyloid-b (non-redox-based
application) (Zhang et al., 2016).
Spectroscopic Probes
Spectroscopic probes have been extensively investigated and widely used in many fields due to their
powerful capability of enlightening and elucidating structural and/or functional features of small/
macro-molecules. Several spectroscopic tools are available in literature. However, only a few specific,
efficient, and less toxic designed small metallo-peptide-based probes are available in literature. Nature
provides a small ATCUN motif that represents a promising spectroscopic toolbox due to its small size,
causing minimal perturbation in protein structure and function. The utility of ATCUN as a spectroscopic
probe is studied by artificially introducing it into protein or peptide. This motif binds, specifically,
paramagnetic transition metal ions like CuII ion to originate a CuII-ATCUN derivative that is useful
for paramagnetic NMR study (Donaldson et al., 2001; Mal et al., 2002; Gaponenko et al., 2000; Brath
et al., 2015). This NMR study can provide valuable information on long-distance interactions
between metal ions and surrounding groups. This probe is also widely used as a universal fluorescence
quencher that is highly suitable for various pharmaceutical and biomedical applications as discussed
below.
Paramagnetic NMR Reporter. Paramagnetic-NMR has been acknowledged as a powerful tool for the
study of biomolecules when the first time this tool successfully solved the solution structure of metal-
loproteins (Banci et al., 1994). Paramagnetic-NMR is well established (Clore and Iwahara, 2009), and its
probe is widely used to obtain valuable information about the structure and function of biomolecules
(Otting 2010). Those proteins in which paramagnetic transition metal ions are already present or the
one in which diamagnetic transition metal ions are replaced, can be used as a paramagnetic probe
for protein structural studies, including protein-protein interaction or protein-nucleic acid interfaces
in folding and unfolding proteins (Cerofolini et al., 2018; Piccioli and Turano, 2015; Balayssac et al.,
2008). For other proteins, paramagnetic metal binding scaffold, which is absent, can be introduced
either by genetic engineering (Barthelmes et al., 2011) or chemically covalent attachment with wanted
proteins or peptides. The short, three-residues CuII-binding ATCUN motif acts as a paramagnetic NMR
probe where CuII ion shows slow electron spin relaxation that causes broadening of proton NMR res-
onances (Clore and Iwahara, 2009; Viles et al., 1999; Kalverda et al., 1996). Donaldson et al. first suc-
cessfully genetically introduced artificial ATCUN tag into multi-domain human ubiquitin protein (Phil-
lips et al., 2001; Huang et al., 1999). CuII-ATCUN-ubiquitin, a paramagnetic probe, is a suitable
candidate for extracting long-range distance restraints from NMR study, which is useful for structure
refinement (Donaldson et al., 2001). In this regard, Mal et al. had also designed a CuII-ATCUN-protein
model system (Maiti et al., 2017b), where CuII-ATCUN domain acts as an NMR-probe for understanding
the interaction mechanism between protein calmodulin (CaM) and its target serine/threonine protein
kinases (CaM kinases). It is a very useful NMR technique. Therefore, it is rapidly growing in a wide array
of intermolecular interactions of biomolecules. Yu et al. employed Cu-GCH as a paramagnetic NMR
probe that characterized protein-protein interactions (Yu et al., 2009). In 2017, Maiti et al. also reported
a paramagnetic NMR probe, CuII-ATCUN motif that was inserted into N-terminus of ORP for under-
standing the molybdenum/copper heterometallic cluster assembly in protein pocket (Maiti et al.,
2017b). The 1H-NMR study clearly indicates that His53 is affected by Cu
II-ATCUN probe, even though,
it is out of paramagnetic region (the distance between His53 and His3 is 27.9 Å). It is only
possible when two molecules interact with each other in head-to-tail fashion (Figure 3). This CuII-AT-
CUN-ORP derivative provides a model of intermolecular protein-protein interaction (Maiti et al.,
2017a, 2017b).
These paramagnetic studies are expected to get more benefit from the diversity of ATCUN-conjugated
protein model system, and undoubtedly it is a valuable addition into the NMR toolbox for the character-
izing of macromolecular structure-function relation.iScience 23, 101792, December 18, 2020 9
Figure 3. Application of Cu-ATCUNs as Paramagnetic NMR Reporters
(A–C) (A) The paramagnetic NMR probe, CuII-ATCUN is attached at N-terminus of ORP. The crystal structure of apo-
ATCUN-ORP is derived from PDB 2WFB (Najmudin et al., 2009), (B) Paramagnetic 1H-NMR spectrum (600 MHz) of apo-
ATCUN-ORP is titrated with CuII salt (0–80%) in mixture of 50 mM Tris-HCl at pH 7.6/D2O (80/20%) and only His53 (b and
d peaks) and His3 (a and e peaks) amino acid redidues are represented those are highly affected, and (C) Schematically




ReviewFluorescence Sensors. Fluorescence assay is one of themost important optical analytical tools and has a
wide range of applications in the fields of chemistry, biology, clinical diagnosis, food industry, pharmaceu-
tical chemistry, and environmental science because of its high sensitivity, rapid response, and quantitative
yield (Fabbrizzi et al., 1996; Krämer 1998). Fluorescence probes are constructed by combination of two
essential components, fluorophore (chromophore), and the quencher (sensor). Fortunately, naturally
occurring CuII binding ATCUN motif acts as a fluorescence quencher due to its paramagnetic character.
For example, ATCUN motif in BSA selectively binds CuII that significantly quenches the fluorescence emis-
sion (Tian et al., 2004; Kruck et al., 1976) by protein containing tryptophan residues (typical fluorescence
signature of a protein) (Beechem and Brand, 1985). Therefore, this advantage of naturally occurring Cu-
ATCUNmotif has been employed as a chemo-sensors for detection and screening of certain cellular metal
ions, catalytic redox reaction of DNA/RNA cleavage, protease, and bio-imaging.
Several fluorescence probes are designed where fluorophore, 5-(dimethylamino)naphthalene-1-sulfon-
amide (Dns) is attached to the vicinity of the receptor (CuII-ATCUN motif) for detection of Cu ions as
well as catalytic activity of Cu-ATCUN motif (Zheng et al., 2002). By applying this strategy, Torrado et al.
first designed a series of ATCUNmotifs (NH2-G(Xn-Dns)GHG), where amino acid at first position of ATCUN
motif was conjugated by Dns with spacer (X = -CH2, and n = 1, 2 and 3). The spacer makes a distance be-




Reviewefficiently (Torrado et al., 1998). Torrado et al. first successfully applied this method in order to understand
the fate of copper in catalytic DNA/RNA cleavage (Torrado et al., 1998). To expand the utility of Dns fluo-
rophore, Zhen et al. developed a fluorescent chemosensor (Dns-NH2-GGHG), where dansyl fluorophore
was attached into N-terminal amino group, resulting Dns directly participating in the binding with CuII.
This model significantly quenches the emission of fluorophore compared to side branch labeling method
(Zheng et al., 2002). Young et al. also compared CuII binding affinity in H(KDns)HH with other three
short peptides (HP(KDns)DHDH, Ac-DH(KDns)HD, and HP(KDns)DHDH) by fluorescence quenching study
(Young et al., 2015). The fluorescent-labeled (Dns) ATCUN probe is also used on CuO-NPs-based
colorimetric immunoassay in clinical diagnosis for the detection of prostate-specific antigen (Deng
et al., 2019a, 2019b).
This chemo-sensor has been also utilized toward catalytic activity of Cu-ATCUN motif. In this regard, Choi
et al. designed a new fluorescence probe, where the fluorophore, GFP was added next to GGH sequence
by genetically (Choi et al., 2015). Upon addition of CuII, the fluorescence of GFP is quenched by about 85%.
In 2015, Wende et al. redesigned a series of ATCUN conjugated fluorophore (R-NH2-Dap-b-Ala-His-Ser-
Ser-CONH2; R = fluorophore = Rhodamine B, dansyl chloride and fluorescein isothiocyanate) derivatives
that significantly cleaved DNA through oxidative pathway. The fate of metal ion (CuII), during the redox
process, was monitored by fluorescence studies (Wendea and Kulak, 2015).
Protease activity is also detected by fluorescence assay. In this assay, generally, the substrate peptide for pro-
tease is attached with a pair of fluorophore-quencher system. Deng et al. (Deng et al., 2018) reported three
fluorophore labeled peptides including EVNLDAHFWADK-Dns, and DAHFWADK-Dns (or SGHDEVDK-Dns)
as proteases model for b-secretase (as known as precursor of amyloid) (Haass and Selko, 2007) and cas-
pase-3 (central mediator of cell apoptosis) (Thornberry et al., 1997; Boeneman et al., 2009), respectively. In
this proteases assay, initially, almost no change in the fluorescence signal intensity is observed even upon
addition of CuII in EVNLDAHFWADK-Dns but after cleavaging in-between L and D amino acid residues in
EVNLDAHFWADK-Dns by b-secretase (Folk and Franz, 2010), CuII binds ATCUN motif (DAH) in fluoro-
phore-labeled fragment (DAHFAWADK-Dns), that significantly reduces the fluorescence intensity (Figure 4).
This result shows the inhibition of b-secretase activity. As a result, b-secretase can be used as a therapeutic
target for AD (see next section). The other proteases model (caspase-3), SGHDEVDK-Dns with CuII exhibits
poor fluorescence signal due to the presence of ATCUN motif (SGH) that strongly binds CuII as a quencher.
After proteases by caspase-3, the fluorophore-labeled fragment (K-Dns) is separated from CuII-ATCUN and
shows good fluorescence signal. This result may be potentially useful as fluorescence imaging for detection
of cell apoptosis.Figure 4. Application of ATCUNs as Fluorescent Reporters
Fluorescence emission of proteases models, b-secretase (A) and caspase-3 (B) is quenched by CuII-ATCUN. Dns;
flurophore. Modified from Deng et al., 2019b.




ReviewIn the living system, copper-homeostasis is a complex process. Prior to entry into cell, Cu is present
mainly as CuII state and ensures copper homeostasis under physiological conditions by one of the
most important proteins, albumin, which represents as labile Cu pool in human blood (Harford and Sar-
kar, 1997; Laussac and Sarkar, 1984). This labile copper pool has clinically significance as potential
markers of copper-related pathologies (Lowe et al., 2017; Maiti and Moura, 2020). Therefore, measure-
ment of this labile copper pool in biological samples is of considerable interest by fluorescence study.
Quite recently, Falcone et al. (Falcone et al., 2020) have reported a turn-off luminescent sensor for
CuII, which combines ATCUN motif with long-lifetime luminophore, lanthanide (i.e. Tb3+), enabling
CuII detection in biological-like media.
Inhibition of Amyloid-b Toxicity
Above section, Figure 4 shows that the model peptide is cleaved to generate ATCUN fragments by b-sec-
retase. It is well known that the formation of amyloid b-peptide (Ab) by b-secretase is considered as a key
step for the AD (Deshpande et al., 2006). The extracellularly released Ab has different isoforms, which
include Ab140, Ab142, and N-truncated Ab442 members. Among them, Ab442 isoforms of Ab family is
high abundance in brains of healthy and AD human, representing a dominant species in AD (Portelius
et al., 2010). Other than, Ab442 has strong ability to bind Cu
II, that not only induces Ab aggregation
into cytotoxicity elements but also generates reactive oxygen species (ROS), causing AD (Faller 2009;
Jha et al., 2017; Young et al., 2014; Cheignon et al., 2017).
Mital et al. reported that a model peptide, Ab416 binds Cu
II with binding affinity, cK7.4 of 3.4 x 10
13 M1,
which is stronger than Ab1x (1010 M1) (Mital et al., 2015) but almost same in HSA (1013 M1) (Bos-
sak-Ahmad et al., 2020; Pushie et al., 2019). The electrochemical response of CuII-Ab416 shows a main irre-
versible peak at 1.04 V (vs. NHE) that is assigned to CuIII/CuII redox couple. An additional peak at lower
redox potential (0.04 V vs. NHE) is assigned to the CuII/CuI redox couple that can be mediated by
reducing agent like ascorbate (Mital et al., 2015). Note that Ab442 peptide has two copper binding sites,
(1) N-terminal ATCUN site binds CuII strongly, suggesting redox silent site, and (2) bis-His motif (at 13th and
14th positions), binds CuII relatively low affinity, suggesting redox active site, that facilitates the reduction of
CuII to CuI. Upon addition of biological reductant i.e. ascorbate to CuIIAb4-6, Cu
II in bis-His is reduced to
yield His-CuI-His complex, while the remaining CuII in ATCUN site is unaffected (Figure 5) (Pushie et al.,Figure 5. Ab4-x Represents the ATCUN (Blue), Bis-His (Green) and Recognition Sites (Orange)
In presence of copper, Ab can produce aggregated as well produce HO, but upon addition of apo-ATCUN, Cu is trapped
by ATCUN and inhibit the aggregation of Ab.




Review2019). Nature designs such type of ATCUN site in Ab4x peptide because it may trap Cu
II under oxidative
stress conditions, but in excess, it crosses the ability to bind CuII, and thereby developes Ab toxicity. There-
fore, designed ATCUN motifs could be used as Cu-chelators for treatment of AD (Folk and Franz, 2010;
Robert et al., 2015). For instance, a designed ATCUN motif, such as DAHK (replica of HSA) has stronger
binding affinity of cK7.4  1014 for CuII and shows redox silence against ascorbate (Gonzalez et al., 2018;
Rozga et al., 2007). Upon chelation of CuII by DAHK from Ab, the reduction of CuII is inhibited by ascorbate,
and thereby retards ROS production.
In addition, the hydrophobic part of Ab sequence, Ab1620 (KLVFF) has strong tendency for Ab aggregation
(Goyal et al., 2017). Therefore, Ab1620 represents a promising drug target for the development of the pep-
tide based inhibitor. For instance, designed KLVFF peptide acts as an Ab inhibitor and has good outcome
(Goyal et al., 2017). Several experimental observations conclude that a hybrid complex, Cu-ATCUN-inhib-
itor strongly suppresses the aggregation of Ab, as well as ROS formation compared to Cu-ATCUN or inhib-
itor alone (Zhang et al., 2016; Jensen et al., 2012). In this regard, ATCUN motif is conjugated with peptide
inhibitor to generate a bifunctional peptide that has ability to disaggregate Ab and also to chelate CuII ions.
Faller et al. designed a bifunctional peptide by combination of DAHK with inhibitor (Ab1220 or Ab1320),
that reduces the HO, formation in cell culture (Jensen et al., 2012). Similar way, Yuan et al. designed a
bifunctional peptide GGHRYYAAFFARR, which significantly suppressed the cytotoxicity of the Cu-Ab com-
plex (Zhang et al., 2016) (Figure 5). Based on this concept, Meng et al. have also reported, recently, a cock-
tail peptide, RTHLVFFARK, that retards the aggregation of Ab, and thereby suppresses the cytotoxicity of
Cu-Ab40 in cell culture (Meng et al., 2018). These findings may guide in the development of peptide-based
inhibitors for treatment of AD.
PET Imaging
The radioactive 64CuII-ATCUNderivatives are thought to be a potential PET candidate for hypoxia (Wadas et al.,
2010; Xie et al., 2016; Walke and Ruthstein, 2019). Hypoxia (or oxygen deficiency) is a hallmark of tumor-specific
microenvironment (Brown andWilson 2004). Therefore, PET-imaging of hypoxia is a very important technique to
visualize the target molecule in vivo. For clinical diagnosis, the stability of metallo-peptide in blood plasma and
transportation of metallo-peptide to the target site are key factors. Miyamoto et al., designed a series of 64Cu–
ATCUN–octreotide derivatives (ATCUN = YYH, VVH, NNH, TTH, GGH, and DDH), where ATCUN motif is con-
jugated with tumor-targeting peptide, octreotide (Oct), and tested the stability of these derivatives in blood
plasma for medical applications (Figure 6) (Miyamoto et al., 2016). Among them, 64Cu-YYH–Oct and 64Cu-
VVH-Oct are highly stable in blood plasma (85.8% and 79.1%, respectively, after incubation of 2 hr). The octreo-
tide, analog of somatostatin, has high affinity for somatostatin receptor, which is highly expressed in various tu-
mor cells, mostly neuroendocrine tumor (Martino et al., 2010). Therefore, octreotide is used as a specific molec-
ular target for imaging therapy (Sun and Coy, 2011). Among them, the 64Cu–YYH–Oct derivative shows the
highest stability in blood plasma and reaches to target tumor cell in tumor-bearing mouse model (Miyamoto
et al., 2016). Therefore, this cocktail complex, 64Cu-ATCUN-octreotide derivative is a potential candidate for
PET-imaging. Therefore, more research is needed to design a more stable 64Cu-ATCUN derivative that will
be exploited more in clinical practice for hypoxia imaging in future.Figure 6. 64Cu-ATCUN-Octreotide Model of Somatostatin Receptor (Targeting Tumor Cell) Providing PET
Imaging
R1 and R2; Y, V, N, T, G, and D amino acids.Redox-Based Applications
Oxidation-reduction processes are considered as a heart of chemical and biological reactions. Nature uses




ReviewChemists have learnt how to adopt naturally occurring scaffolds as catalysts and also explore for new per-
formances. Beside the spectroscopic probe (above discussion), the designed metal-ATCUN derivatives,
especially Cu-, Ni- and Co-ATCUN serve as a suitable catalytic metal-center for various catalytic activities,
including DNA, RNA cleavage, protein inactivation (Harford and Sarkar, 1997; Mack and Dervan, 1992; Jin
and Cowan, 2005, 2007; Agbale et al., 2016; Yu and Cowan, 2017a, 2017b; Gonzalez et al., 2018), small
molecule activation (multi-electrons, multi-protons reactions) (Deng et al., 2018; Kandemir et al., 2016;
Guo et al., 2018), as well as modification of biomolecules (protein-protein interaction, nitration of tyrosine)
(Maiti et al., 2019; Horowitz et al., 2012; Brown et al., 1998). The catalytic metal center in M-ATCUN deriv-
ative works in two ways. One, the catalytic metal center generates ROS, which are mainly focused toward
the cleavage or modification of biomolecules. Second, the same catalytic metal center activates the small
molecules through the same redox cycle.
DNA Cleavage
Metallodrug is of significant interest in the development of nuclease (DNA and RNA cleavage) related
human diseases at the genetic level, especially, cancer, human immunodeficiency virus (HIV), and hepatitis
C virus (HCV) (Harford and Sarkar, 1997; Mack and Dervan, 1992; Jin and Cowan, 2005, 2007; Agbale et al.,
2016; Yu and Cowan, 2017a, 2017b; Gonzalez et al., 2018; Mjos and Orvig, 2014). In 1983, Pauling et al.
remarkably investigated (Kimoto et al., 1983) the antitumor activity of the CuII-GGH (Cu-ATCUN) complex
against Ehrlich ascites tumor cells. That investigation raised the interest in metal-ATCUN motifs toward
DNA cleavage (Harford and Sarkar, 1997; Mack and Dervan, 1992; Jin and Cowan, 2005, 2007; Agbale
et al., 2016; Yu and Cowan, 2017a, 2017b; Gonzalez et al., 2018; Cowan 2001; Detmer et al., 1996; Patward-
hana and Cowan, 2001; Pamatong et al., 1996).
Generally, in presence of AscH/H2O2, metal-ATCUNderivatives actively generate ROS such as hydroxyl radical






/) of deoxyribose rings to initialize strand-breaks of DNA (Pogozelski
and Tullius, 1998) leading to yield variety of cleavage products (Burrows and Muller, 1998) (Figure 7).Figure 7. Schematic Representation of M-ATCUN Induces Oxidatively DNA Strand Scission by Sugar-Hydrogen






(modified from Pogozelski and Tullius, 1998). B = Nucleobase.




ReviewIn practical applications, the selectivity and efficacy of DNA strand scission aremodulated by proper design
of ATCUN motif. The nuclease activity of M-ATCUN derivatives could be influenced by some key factors
(Figure 8), including overall higher positive charge on M-ATCUN, inclusion of positively charged amino
acids (such as Arg or Lys in ATCUN motif), planarity of catalytic site, stereochemical/geometrical orienta-
tion (D/L configuration), position and size of amino acid (Jiang et al., 2007). To date, the most common
target sites of DNA are the minor and major groove and G-quadruplex (guanine-rich nucleic acid se-
quences of telomere DNA) (Figure 8) (Jiang et al., 2007).Figure 8. Selectivity and Efficacy of DNA Strand Scission Are Modulated by Proper Design of ATCUN Motif
(A–D) (A) Two-dimentional representation of DNA showing targeting sites, minor and major groove, (B) quadruplex
structure of telomeric DNA, (C) top and bottom faces of square planar geometry of M-ATCUN (M =CuII, NiII and CoII), and
(D) introduction of positive charge amino acid (positive charge and D/L) at first, second, and or fourth positions.To meet this DNA cleavage efficiency, varieties of M-ATCUN-derivatives have been developed. In this sim-
ple modular design of M-ATCUN, MII ion is in a square planar configuration having two accessible binding
faces that promote effective DNA cleavage (Mack and Dervan, 1990, 1992; Jin et al., 2007; Mack et al., 1988;
Mahmoudi and Sarkar, 1999; Harford et al., 1996). Binding affinity of M-ATCUN toward DNA highly de-
pends on side chain of amino acid at the periphery of ATCUN motif. When periphery functional groups
of entirely designed M-ATCUN derivatives are the same molecular recognition of DNA (e.g. guanidinium,
amine, and amide moieties), those M-ATCUN candidates selectively bind and effectively cleave the DNA
strands (Harford and Sarkar, 1997; Mack and Dervan, 1992; Jin and Cowan, 2005, 2007; Agbale et al., 2016;
Yu and Cowan, 2017a, 2017b; Gonzalez et al., 2018).
Historically, the NiII-GGH derivative was first studied as a potential nuclease candidate (Mack and Dervan,
1992; Liang et al., 1998). Alternatively, nuclease activity was also being tested by CuII-ATCUN derivatives.
The intensive work was carried out on DNA cleavage by Cu/Ni-ATCUN derivatives. Long et al. have inves-
tigated extensively the nuclease activity by Ni-ATCUN derivatives. These derivatives preferential cleave the
minor groove of DNA (at AT-rich regions) but catalytic efficacy depends on the stereochemistry, charge,
and position of amino acids in ATCUN motif (Mack and Dervan, 1992; Liang et al., 1998). DNA cleavage
chemistry by Cu/Ni-ATCUN derivatives has been also well documented by Cowan et al. (Jin and Cowan,
2005). For instance, the reactivity rate of Cu-KGHK derivative toward oxidative DNA cleavage is higher
than the simple Cu-GGH derivative (Jin and Cowan, 2005). The other metal-derivatives, NiII/CuII-KKH
and NiII/CuII-KGHK have been also studied where former M-derivative exhibits slightly higher cleavage
rate than other (Jin and Cowan, 2005). This result indicates that the placement of Lys residue at first position




Reviewthe first position Lys (Arg analog) in KGH sequence is directed toward minor groove of DNA to generate
iso-helical metallopeptide, which facilitates to yield stable DNA-ATCUN adduct, while the second position
Lys is directed away from the minor groove of DNA. The slightly greater activity is simply accounted for by
the strong electrostatic interaction between DNA (negative charge) and Lys or Arg (positive charge amino
acid). In general, both Cu- and Ni-ATCUN derivatives show increase in DNA cleavage activity with
increasing number of positive charge amino acid, such as Lys and Arg residues in ATUCN motif, that
corroborate with redox potential (Jin and Cowan, 2005, 2007). Therefore, DNA cleavage activity does
not depend only on positive charge of side chain amino acid residues but also important for proper orien-
tation between Cu-ATCUN motif and DNA (Jin and Cowan, 2007).
The DNA cleavage chemistry is not a randomprocess where square planar geometry ofM-ATCUN interacts
at minor groove and abstracts mainly C4
/-H from deoxy-ribose ring (Jin and Cowan, 2007; Pushie et al.,
2019). The abstraction of C4
/-H is facilitated by the formation of transient H bonds between square-planar
‘‘edges’’ of M-RGH (or Lys analog) derivative (H-bond donors, N-terminal N-H protons, imidazole pyrrole
N-H, and Arg side-chain) and minor groove of AT-rich regions of DNA (H-bond acceptors; O2 of T and N3
of A) (Figure 9). The DNA cleavage is also highly influenced by the stereochemistry of amino acids (Fang
et al., 2004, 2006; Nagane et al., 2001). Switching from L- to D-amino acids at positions 1 and 2 in ATCUN
motif, the D-ATCUN derivative improves the nuclease activity but shows lesser selectivity. In comparison
with L-ATCUN, the D-ATCUN derivative is sterically lesser hinder complex that allows M-ATCUN deeper
insertion into minor groove of DNA, resulting increase the DNA cleavage efficiency (Fang et al., 2006).Figure 9. Two-Dimentional Representation of Interaction between NiII-RGH and the Minor Groove of Model
DNA, 5/-d(CGCG4A5ATTCGC9G)2 through H-Bonding (Dotted Lines)
(Modified from Fang et al., 2004).Interestingly, Ni-ATCUN has ability to produce another reactive species, oxy-sulfur radical through the
same redox cycling between NiIII and NiII in presence of sulfite/oxygen, that also significantly damages
the biomolecules including DNA, RNA, and proteins (Neta and Huie, 1985; Brandt and van Eldik, 1995).
For instance, Ni-KGH shows the single- and double-stranded DNA damage in presence of Na2SO3 and
O2 (Muller et al., 1997).
Cleavage of Telomeric DNA. DNA has another important therapeutic target site, G-quadruplex (G4)
that is secondary structure of guanine (G)-rich sequence (TTAGGG) in telomeric DNA (Zahler et al.,
1991). This G4-tetrad sequence is not read by the RNA template of telomerase complex (Xie et al.,
2016), resulting downregulation of the telomerase activity in normal cells but up-regulation in tumor cells
in human (>85%) (Kim et al., 1994; Sfeir et al., 2009). Therefore, G-quadruplex telomeric DNA plays an
important role in cancer biology, suggesting as potential anticancer targets (Neidle 2017). To date, a




Review(Nadai et al., 2018). Alternative drugs are required for selective G4s cleavage. To achieve this goal, Cowan
et al. (Yu et al., 2015) designed a Cu-GGHK-Acr derivative, where Acr (3,6,9-trisubstituted acridine) was a
recognition domain of G-quadruplex (Figure 10B) that facilitated to bring the position of catalytic center,
Cu-GGHK in close proximity to G4-tetrad through the p-p interaction between acridine ring and G4s sur-
face (Yu et al., 2015; Campbell et al., 2008). So, this derivative selectivity cleaves the DNA sequence of
G-quadruplex model (5/-FAM-dATT(TTAGGG)3) at A1-G2 and T6-A7 nucleotides sites, resulting inhibition
of cancer cell division (Figure 10A) (Yu and Cowan, 2017a, 2017b; Yu et al., 2015). Cu-GGHK-Acr derivative
has been also tested on cancer cell (MCF7 and HuH7) and shows significant anticancer activity against both
cell lines.Figure 10. Cleavage of Telomeric DNA by designed Cu-ATCUNs
(A) Crystal structure of G4 telomeric DNA (PDB: 1KF1 (Yu et al., 2015)) shows the selective cleavage sites by (Cu-
ATCUN)2ND (black arrows with ND) and Cu-ATCUN-Acr (black arrows with Acr). ND; naphthalene diimide derivatives,
ND1 and ND2 represents the two copper sites in (Cu-ATCUN)2ND, Acr; acridine.
(B and C) (B) and (C) showing two-dimensional representation of Cu-GGH-Acr, and R2-ND derivatives (R = Cu-ATCUN =
Cu-GGH, Cu-DGH and Cu-GDH) respectively (Modified from Yu et al., 2019).It is expanded to design a series of G-quadruplex telomeric DNA cleavage models that show selective and
rapid telomere reduction in cancer cell (Yu et al., 2019). In this assay, three different Cu-ATCUN derivatives
(Cu-GGH, Cu-GDH, and Cu-DGH) are selected, and these are conjugated with naphthalene diimide (ND) de-
rivative (as a G-quadruplex recognition moiety) through aspartate side chain (D) or C-terminal carboxylate of
ATCUN motif (Figure 10C). Like acridine, ND also interacts with G-tetrad through p-p interaction that facili-
tates to bring the DNA cleavage moiety, Cu-ATCUN in close proximity to this G-tetrad. In addition, binding
affinity of ND derivatives towardG-tetrad is higher (at least two-fold) than acridine isomer, resulting significant
inhibition of cancer cell growth (Cuenca et al., 2008). Both Cu-GDH-(p/m)ND derivatives exhibit the highest
level of telomere reduction in cancer cells. These (Cu-ATCUN)2-ND derivatives have two Cu-catalytic sites
that have different binding patterns on G-tetrad. One Cu-center (ND1) is close to A1-A3, T6-A7, and G20-
G22, whereas the second Cu-center (ND2) is close to G14, and G15 in G4-tetrad, resulting selective cleavage
the nucleotide bases (Figure 10A). All (Cu-ATCUN)2-DN derivatives are also tested on human cancer cells
(MCF7). Among them, (Cu-GDH)2-(p)DN significantly inhibits human cancer cell proliferation. Thus, the above
observations emphasize to design efficient nuclease catalyst for the treatment of G4-related diseases.
RNA Cleavage
Like DNA, RNA is another important therapeutic target (Pearson and Prescott, 1997). RNA, a genetic




ReviewHCV. The virus RNA is a complex structure possessing a set of sub-domains that are attractive for potential
therapeutic targets. The cleavage of RNA in HIV or HCV by M-ATCUN has been studied through oxidative
pathway like DNA (Joyner and Cowan, 2011; Bradford and Cowan, 2012; Jin and Cowan, 2006; Ross et al.,
2015). RNA has some degree of resistance to oxidative cleavage with respect to DNA due to the presence
of additional 2/-hydroxyl (2/-OH) in sugar-phosphate backbones (Thorp 2000). This 2/-OH attributes variety
of secondary and tertiary structures, which originate a complicated reactivity pattern. However, the oxida-
tive reactivity pattern of RNA has a firm relation with DNA, such as hydrogen abstraction. The oxidation of
RNA is initiated by H-atom abstraction in presence of ROS, which is produced by catalytic metal center
(Zhao et al., 2018; Crich andMo, 1997). The selective RNA cleavage is also employed by an analogous strat-
egy of DNA, where RNA cleavage domain (M-ATCUN) is coupled with RNA targeting domain.
HIV RNA Cleavage. HIV-1 gene expression is regulated by two virally encoded proteins, Rev and Tat.
HIV-RNA binding protein (arginine rich peptide) is derived from the HIV-1 regulatory proteins, Rev that in-
teracts with the Rev response element (RRE) of HIV-1 to generate the Rev-RRE complex (Battiste et al.,
1996). The formation of this complex is an essential step in the viral replication cycle (Frankel and Young,
1998). To achieve this, Cowan et al. have designed antiviral metallodrugs, M-ATCUN-TRQARRNRRRR-
WRERQR (M = Cu/Ni/Co and ATCUN = GGH and KGHK) that selectively binds and oxidatively cleaves
the RRE stem-loop of HIV RNAmodel (Joyner and Cowan, 2011; Jin and Cowan, 2006). The specific binding
pocket (A26 and U30 nucleotides) and selective cleavage sites (C9, G6, and U5 nucleotides) in RNA are also
shown in Figure 11. The adjacent G-G base pair in backbone of RRE RNA creates a specific binding pocketFigure 11. Selective Cleavage of HIV RNA by Cu-ATCUN-Rev
(A) Schematic illustration of the stem loop IIb (SL-IIb) of RRE RNA of HIV showing the cleavage site, as well as binding
pocket.
(B) Crystal structure of RRE RNA SL-IIb complexes with an Rev peptide (purple) (PDB: 1ETF) showing the main cleavage
sites which are shown by green highlighted as well as red arrows (U5, G6, and C9). The catalytic center, M-ATCUN (red star)
may be conjugated with N-terminus of Rev. The structure is modified from Joyner et al. (2011).




Reviewthat allows the incoming Rev peptide for specific recognition (Battiste et al., 1996). The oxidative RRE RNA
cleavage by Cu-GGH-Rev or Cu-KGHK-Rev derivative is similar to DNA cleavage where C4/-H abstraction is
the major product (Joyner et al., 2013a, 2013b). Rationally designed Cu-ATCUN-Rev derivative is a prom-
ising candidate for selective cleavage of the RRE site of HIV to inhibit the virus replication cycle. The selec-
tive RNA cleavage by designedM–ATCUNderivatives has been well documented but at the same time, the
practical requirements of cell delivery and activity in vivo of metallopeptide are also needed. A series of
metallopeptides have been designed and evaluated the intracellular delivery and cleavage activity toward
the target HIV-1 RRE RNA in both vitro and vivo (in Escherichia coli and mammalian cell) by cellular fluores-
cence assay.
Figure 12 shows that the plasmid encoded RRE RNA sequence is fused to C-terminal of GFP. N-terminus of
Rev peptide (TRQARRNRRRRWRERQR) is coupled with ATCUN (GGH) through a linker, Gx (glycine (G)x,
x = 0, 1, 2, 4, 6 corresponding peptides are Rev1, Rev2, Rev3, Rev4, Rev5, and Rev6, respectively) (Jin
and Cowan, 2007; Hocharoen and Cowan, 2009). Among them, Rev1, Rev2 peptides with shorter linker,
and their copper derivatives significantly reduce the cellular expression of GFP (Plasmid encoded GFP-
RRE), suggesting optimal RRE RNA cleavage activity. Interestingly, both metal bound or metal-free state
of Rev1 and Rev2 derivatives show similar cellular activity, suggesting both metal free derivatives are
able to recruit the metal ions from a cell by ATCUN motif.Figure 12. Schematic Representation of the Cellular Expression of GFP (Plasmid Encoded GFP-RRE) Is Induced by
CuII-ATCUN-Rev
(Modified from Hocharoen and Cowan, 2009).Another important site-specific RNA cleavage target is the hairpin-loop (stem loop), trans-activation-
responsive region (TAR) RNA from HIV-1 that serves as specific binding site for arginine-rich tat protein
(RKKRRQRRRPPQ) or Tat derived peptide (Aboul-ela and Varani, 1998). Long et al. reported that all NiII-
Xaa-Gly-His (Xaa = Gly, Lys, or Arg) derivatives selectively cleaved the stem loop of TAR RNA of HIV-1 (Brit-
tain et al., 1998).
HCV RNACleavage. The designed catalytic metallodrugs, M-ATCUN derivatives also cleave the RNA of
HCV selectively. The internal ribosomal entry site (IRES) of HCV RNA is an important component for the life
cycle of the HCV. Therefore, HCV IRES RNA containing stem loop IIb and IV (SLIIb and SLIV) are promising
therapeutic targets (Figure 13) (Kieft et al., 2001; Lukavsky et al., 2003). Based on previous approach,
M-GGH-YrFK derivative (Lower case ‘r’ represents D-arginine) is designed, which selectively binds andiScience 23, 101792, December 18, 2020 19
Figure 13. Selective Cleavage of HCV RNA by M-ATCUN Derivatives
(A and B) (A) Two-dimensional representation of subdomain SL-IIb RNA of HCV, and (B) crystal structure of HCV SL-IIb
RNA (PDB: 1P5N) showing the main cleavage sites (highlighted blue and orange color) by CuGGHYrFK or CuGGhyrfk




Reviewcleaves the stem loop-IIb (SLIIb) of the HCV IRES (Bradford and Cowan, 2012). The tera-peptide, YrFK, a
dermorphin analog known as DALDA, highly specific m-opioid receptor agonist (Samii et al., 1994), binds
to targeting domain, SL-IIb of HCV IRES (Bradford and Cowan, 2012). The designed metallodrug, Cu-
GGH-YrFK-amide derivative is examined on model oligonucleotide (50-fluorescein-GGCAGAAAGCGU-
CUAGCCAUGGCGUUAGUA UGCC-30) of SL-IIb in vitro and in HCV cell. The cellular replicon assay of
Cu-GGH-YrFK-amide derivative shows enzyme-like turnover (KM of 0.85 mM and kcat of 0.53 min
1). The
incorporation of D-Arg (r) into YrFK sequence enhances the binding affinity and reactivity of Cu-GGHYrFK
toward SLIIb of IRES RNA. In addition, a designed Cu-GGh-yrfk derivative (lower case indicates the D-form
of amino acid) is also evaluated for binding and reactivity patterns against RNA of HCV. Both compounds
show the similar HCV cellular replicon assay and high stability in vivo that meet to the US-FDA approved
HCV replicon assay (Bradford et al., 2014). Interestingly, Cu-GGh-yrfk, exhibits major cleavage sites, U14
and A15, whereas Cu-GGH-YrFK exhibits a wider range of cleavage sites A6-G9 of HCV SLIIb RNA (Fig-
ure 13). This concept is expanded to design a series of L-analog of Cu-GGH-YrFK derivative where recog-
nition domain, YrFK is shuffled with existing amino acid or substituted other amino acids like A, D, N, and K
(YRFK, ARFK, YAFK, YRAK, YRFA, KFRY, DRFK, NRFK, KRFK, and FRFK) in order to understand the impact of
each amino acid residue toward SLIIb RNA binding and cleavage efficiency (Ross et al., 2017). Binding af-
finity and reactivity patterns of each metallo-peptide are modulated by stereochemistry, charge, size and
position of amino acids in the targeting domain. For instance, Cu-GGh-YRFK and Cu-GGH-FRFK show the
low catalytic efficiency compared to Cu-GGH-YrFK and Cu-GGh-yrfk (Ross et al., 2017).
Another promising therapeutic intervention of metallopeptide is stem loop IV (SL-IV) of HCV IRES RNA. SL-IV
possesses ribosome assemblyGCACdomain andAUG start codon (Mondal et al., 2008) (Figure 14). The LaR2C
peptide, analog of human La protein, binds with SL-IV HCV IRES resulting inhibition of HCV replication (Pudi
et al., 2003). TheHCV replicon assay of designedmetallodrugs, Cu-GGH-KYKETDLLILFKDDYFAKKNEERK and
Cu-GGH-KYKETDL containing LaR2C peptide (KYKETDLLILFKDDYFAKKNEERK and truncated sequence,
KYKETDL of La protein are shown in Figure 14), are examined on model oligonucleotide (5/-fluorescein-20 iScience 23, 101792, December 18, 2020
Figure 14. Inhibition of HCV Replication by La Protein
(A) Two-dimensional representations of SL-IV RNA showing AUG start codon (pink circle) and 50-GCAC-30 sequences as a
potential recognition site (orange circle).
(B) NMR solution structure of the human La protein is derived from PDB 1S79. LaR2C peptide,
KYKETDLLILFKDDYFAKKNEERK is highlighted as green and blue color. The truncated 7-mer, KYKETDL is highlighted as




ReviewGGACCGUGCACCAUGAGCACGAAUCC-3/) of HCV IRES SLIV RNA in vitro (Ross et al., 2015). In this replicon
assay, both derivatives show significant efficacy. Cu-GGH-KYKETDLLILFKDDYFAKKNEERK exhibits most
significant cleavage sites, G15 and A16, whereas Cu-GGH-KYKETDL exhibits the main cleavage site, G8,
representing a part of GCAC domain. Still need to develop these drugs for the treatment of human HCV
infection.
Inhibition of Protein Activity
Inhibition of enzyme activity by drugs is another novel approach to cure the human diseases. Basically, drug
blocks the active site of enzyme to inhibit the enzyme activity, and thereby arrests the enzyme related dis-
eases. The diseases associated proteins such as human angiotensin converting enzyme (ACE) (Gokhale and
Cowan, 2005; Joyner et al., 2012; Hocharoen et al., 2013), carbonic anhydrase-I (Gokhale et al., 2008), and
sortase-A (Fidai et al., 2014) are potential therapeutic targets. Herein, M-ATCUN is conjugated with sub-
strate inhibitor to generate a cocktail complex that basically plays the dual role: (a) selective binding
and (b) oxidative modification of amino acid residues in proteins/enzymes.
Human ACE. The ACE, a Zn-containing metalloenzyme, converts the natural deca-peptide
(DRVYIHPFHL) angiotensin I to angiotensin II as a potent vasoconstricting octapeptide (DRVYIHPF) and
degradation of vasodilator nanopeptide bradykinin (RPPGFSPFR), leading to increase in blood pressure
(Crackower et al., 2002). ACE inhibitor such as lisinopril is a potential drug candidate for the treatment
of hypertension and heart failure. The binding mode of lisinopril (N2-[(S)-1-carboxy-3-phenylpropyl]-L-
lysyl-L-proline) with Zn-site in ACE is shown in Figure 15A (Natesh et al., 2003). Interestingly, the backbone
of lisinopril is very close to ACE substrate, Hip-His-Leu that contains benzene group at S1 site, His group at
S1/site, and dimethyl group at S2/site of lisinopril (Figure 15B).
In general, lisinopril (inhibitor) makes inactive the somatic-ACE-1 (isoform of ACE family) activity by replac-
ing the substrate from metalloenzyme-substrate complex to yield metalloenzyme-inhibitor complex, but it
is a reversible process. The alternative of reversible inhibitor (lisinopril) is an M-ATCUN-inhibitor derivative
that plays for irreversible inactivation of sACE-1 enzyme by modification of biomolecules through oxidative
pathway (Figure 16).
Cowan et al. demonstrated the catalytic inactivation of ACE enzyme by using a designed Cu-KGHK deriv-
ative. The attachment of Lys in KGHK is mimicked to the lysine side chain of lisinopril. The inactivation assay
of human somatic ACE-1 (Soubrier et al., 1998) is monitored by the cleavage of the fluorogenic peptide,iScience 23, 101792, December 18, 2020 21
Figure 15. Interaction between Zn-ACE and Inhibitor
(A and B) (A) Partial crystal structure of lisinopril (inhibitor) adduct Zn-active site of ACE (PDB code: 1O86 (Natesh et al.,
2003)), and (B) two-dimentional representation of natural occurring substrate, Hip-His-Leu are showing the binding sites.




ReviewMca-RPPGFSAFK(Dnp)-OH (Mca; methyl coumarin, Dnp; dinitro-phenyl) (Johnson and Ahn, 2000) as a
model of bradykinin. This assay shows the catalytic inactivation (rate constant, k  2.9 G 0.5 X 102
min1) of ACE enzyme with pre-incubation of Cu-KGHK derivative under oxidative conditions (Gokhale
and Cowan, 2005). Based on this result, a newmetallodrug, Cu-GGH-lisinopril is developed that selectively
binds somatic ACE-1 with high affinity (Joyner et al., 2012).Figure 16. Possible Reversible (Simple Inhibitor) vs. Irreversible (M-ATCUN-Inhibitor) Inactivation Mechanism of
Metalloproteins-Substrate with Inhibitor




ReviewThe somatic-ACE harbors two homologous N- and C-domains (Hocharoen et al., 2013). The interest is to
develop metallo-peptide that selectively binds the particular domain in somatic-ACE. Molecular modeling
studies on Cu-GGH-linsinopril within sACE-1 reveals that the Cu in Cu-GGH-lisinopril coordinates nearby
D140 in N-terminal domain, whereas E162 or D377 in the C- terminal domain of sACE-1 (Joyner et al., 2012).
The catalytic inactivation of each N/C-domain of somatic ACE-1 is examined by designed M-ATCUN-
lisinopril derivative (Hocharoen et al., 2013). The M-ATCUN-lisinopril complex shows significant higher
catalytic inactivation rate in N-domain over C-domain of somatic ACE, suggesting optimal orientation of
M-chelate-lisinopril complex within N-domain compared to C-domain (Hocharoen et al., 2013). These
results provide a valuable drug development for other therapeutic targets.
Carbonic Anhydrase. Another Zn-containing metalloenzyme is carbonic anhydrase (CA), which is
responsible for the rapid conversion of CO2 to HCO3
- and protons, involving in various physiological
and pathological processes (Supuran et al., 2003). Overexpression or elevated CA is related to various dis-
eases, which include human diabetes, heart failure, cancer, and glaucoma (Supuran et al., 2003; Supuran
2008). So, CA is an important therapeutic target. The activity of CA is suppressed by a substrate inhibitor,
sulfonamide derivative through CA(Zn)-sulfonamide complex formation (Figure 17) (Khadikar et al., 2005).
This advantage of sulfonamide derivative, p-aminobenzene-sulfonamide (SLN) is utilized as a recognition
domain and it is conjugated with a catalytic domain, Cu-ATCUN (Cu-GGH) to yield a metallo-inhibitor,
Cu-ATCUN-SLN. This derivative selectively binds at the active site of human CA-1 and oxidatively modifies
the possible close proximity (5–20 Å) amino acid residues, including H64, H67, H200, H243, W97, and W123.
Interestingly, no modification of Zn coordinated His residues (H94, H96 and H119), as well as no cleavage
of protein are observed (Gokhale et al., 2008).Figure 17. Crystal Structure of Human CA-I (PDB: 1CZM (Chakravarty and Kannan, 1994)) with Bound
Sulfonamide Inhibitor (Stick Model and also Highlighted by Green Circle)
Highlighted the possible oxidatively modified amino acids, H64, H67, H200, H243, W97, W123 (stick ball model) by Cu-GGH.
Distances of these residues from Zn-center are shown by dotted double headed arrows. The Cu-GGH (red star) is
assumed to coordinate to the NH2-tail of sulfonamide inhibitor (green circle). Modified from Gokhale et al. (2008).Sortase A. Sortase A (SrtA), a membrane-bound bacterial surface adherence protein found in gram pos-
itive bacteria (staphylococcus aureus), is a common cause of many serious hospital- and community-ac-
quired infections and cleaves the amide backbone in-between Thr (T) and Gly (G) residues in LPXTG motif
of the C-terminal cell-wall sorting signal (Cossart and Jonquires, 2000). The bacterial infection can be
halted by inactivation of SrtA protein (Aboul-ela and Varani, 1998). The designed metallopeptides, Cu-
GGHLPETG, Cu-GGHLPET, Cu-GGHGLPETG, and Cu-GGHGLPET containing SrtA-targeting motif,




Reviewresulting inactivation of SrtA protein. The mechanism of enzyme inactivation describes the oxidative modi-
fication of the enzyme active site by Cu-GGH catalytic domain. The head (G) of SrtA substrate, LPETG, is
directed toward the active site containing conserved amino acid sequence, R197-C184-H120. The tail (L) of
LPETG is coordinated with Cu-ATCUN catalytic domain that can modify the close proximity amino acid res-
idues, R197-C184-H120, but there is no evidence for modification of Gly167, Val168, and Leu169 residues (Fig-
ure 18) (Fidai et al., 2014). Interestingly, shortest (GGHLPET) and longest (GGHGLPETG) sequences of met-
allopeptide show a significant higher rate of enzyme inactivation than the moderate-size (GGHGLPET) of
metallopeptide. The shortest peptide provides the better alignment of the catalytic domain, Cu-ATCUN
toward the enzyme active site (R197-C184-H120), resulting higher rate of enzyme inactivation, whereas
longest peptide provides the catalytic center far away from the enzyme active site, but it gives more solvent
exposed catalytic center that produces more ROS. Overall, the shortest metallopeptide shows higher rate
of Cys oxidation in active site of enzyme (Bradford et al., 2014; Fidai et al., 2014).Figure 18. Inactivation of SrtADN59 Activity by Cu-ATCUNs
Superimpose crystal structures of SrtADN59 (Wild (cyano) (PDB ID: 1T2O (Suree et al., 2009)) and mutant Cys184Ala (gray)
(PDB ID: 1T2W (Suree et al., 2009)) with substrate, LPETG (blue)). Cu-GGH (red star) is assumed to bind to the L residue of
substrate where close proximity amino acid residues G167, V168, and L169, and G residue of substrate points toward the
active-site amino acid R197-C184-H120. Modified from Fidai et al. (2014).Peptide-Based Inhibitor of Viral Protease. The viral protease, NS2B/NS3 (non-structural protein) is an
essential for viral replication and maturation, which is a promising pharmaceutical target for flavivirus infec-
tions, including west Nile (WNV), japanese encephalitis, yellow fever (YFV), zika (ZKV), and dengue (DENV)
viruses (Chappell et al., 2008). NS2B-NS3 protease belongs to serine protease, trypsin-like, with a classic
catalytic triad, His-Asp-Ser (Kang et al., 2017; Bazan and Fletterick, 1989). The peptide-based inhibitor ther-
apy is one of the most potential therapeutic strategies for treatment of various viral infections but currently
no drugs are available inmarket. To achieve this, the peptide-based inhibitor is designed by introduction of
ATCUN (GGH) motif into the N- or C-terminus of WNVP targeting peptides such as naphthoylated, ben-
zoylated, or acetylated (Pinkham et al., 2018a, 2018b). All metallo-peptide derivatives show noticeable
decrease in WNVP activity by oxidative modification of amino acids. Particularly, His51-Asp75-Ser135 triad
in WNVP is essential for substrate binding and enzyme activity (Figure 19) (Pinkham et al., 2018a, 2018b).
Overall, the naphthoylated metallo-peptide modifies the active site amino acid residue, Ser135 and addi-
tionally Thr132 and Thr134 residues whereas benzoylated metallopeptide modifies the active site amino
acid residue, Asp75 and additionally Ser71, Lys73 and Glu74 residues, which ultimately lead to the enzyme
inactivation.24 iScience 23, 101792, December 18, 2020
Figure 19. Peptide-Based Inhibitor of Viral Protease
Crystal structure showing oxidative damage to West Nile Virus NS2B/NS3 (PDB: 2FP7). Amino acid residues, green set
(Ser135, Thr132 and Thr134) and orange set (Asp75, Ser71, Lys73 and Glu74) are modified by naphthoylated (Np) and




ReviewOverall, designed metallo-peptide inhibitors (Cu-ATCUN-substrate) give deeper insights on catalytically
inactivation of enzymes activity through protein-substrate interactions, as well as oxidative damage the
amino acid residues, but it remains in cellular replicon study yet. These results help to develop the drugs
in future for antiviral activity in clinical treatments.
Antimicrobial Activity
Worldwide human health is threatened by multi-drug resistant pathogens. Currently, naturally occurring
AMPs have great potential in drug development due to their wide range of activity toward multi-domain
pathogens. Interestingly, the ATCUN motif is also found in naturally occurring AMPs, including histatin,
hepcidin, and piscidin, which serve as natural antibiotics (Alexander et al., 2018; Hancock and Sahl,
2006; Zasloff 2002). M-ATCUN derivatives are to be a novel therapeutics agent against multi-domain path-
ogens. These peptides attack the cell membrane of many pathogens (Gram-negative and Gram-positive
bacteria and fungi) through a common mode of action, such as cell membrane disruption (Brogden
2005; Dawson and Liu, 2006). Human saliva protein, histatin is one of the best natural examples of AMP
that kills many pathogens, suggesting a promising candidate for drug development (McCaslin et al.,
2019; Melino et al., 2006). Melino et al. designed a model of histatin-5 (DSHAKRHHGYKRKFHEHHSHRGY),
known as ATCUN-C16 peptide (C16 representing 16 amino acid residues of the C-terminal of histatin-5;
DSHAGYKRKFHEKHHSHRGY), which shows similar activity of histamine (Melino et al., 2006). Several
studies indicate that ATCUN combined AMPs show more active in antimicrobial activity compared to
ATCUN-free AMP. For instance, clavanin, a naturally occurring AMP is isolated from the hemocytes of
the marine tunicate styela clava and has different forms, including clavanin-A, -B, -C, and -D. Among
them, only clavanin-C contains ATCUN site that can speed up five-fold antimicrobial activity over
ATCUN-free clavanin (Lee et al., 1997). Obviously, incorporation of ATCUN motif into AMPs gives extra
mileage in mode of action of AMPs that facilitates to oxidatively damage the bacteria cell, unlike to simple
electrostatic interaction between positive charge of AMPs and anionic bacterial membrane surface. The
modes of action of AMP with and without ATCUN motif are different as shown in Figure 20. Thus, it moti-
vates to develop and design ATCUN-coupled AMPs derivatives. For instance, the designed ATCUN-AMP
derivatives (Cu-GGHGWRWYCRNH2 and Cu-GGHWRWYCRGGK-NH2) are more efficient compared to the
parent AMPs (Joyner et al., 2013a, 2013b).iScience 23, 101792, December 18, 2020 25




ReviewThe antibacterial activity is also influenced by choice of amino acid in ATCUN motif. Three metal binding
ATCUN motifs, GGH, VIH, and DAH are selected for study of antibacterial activity, in which Cu-DAH
exhibits poor formation of ROS compared to others. The conjugation of Cu-GGH, Cu-VIH, Cu-DAH with
AMP, the Cu-DAH-AMP is likely to be less active in antimicrobial activity than others two (Libardo et al.,
2014). This approach is expanded to design various M-ATCUN-AMP derivatives (ATCUN: GGH, VIH, and
DAH), where AMPs have different binding modes of action such as membrane-disrupting peptides,
(anoplin; GLLKRIKTLL-NH2 sequence) (Ifrah et al., 2005; Konno et al., 2001) pro-apoptotic peptide (PAP;
KLAKLAKKLAKLAK-NH2) (Javadpour et al., 1996; McGrath et al., 2013; Kim et al., 2011), and non-mem-
brane-active peptide (sh-buforin; RAGLQFPVGRVHRLLRK-NH2) (Park et al., 1996, 2000). All derivatives
are tested on antimicrobial activity against four different bacterial strains. Among them, Cu-VIH-anoplin
derivative shows the highest antibacterial activity over others.
This approach is expanded to design an RTH-sh-buforin derivative possessing more positively charged on
ATCUN motif that allows high binding affinity toward DNA over neutral ATCUN motif, VIH-sh-buforin. The
switching from L- to D-amino acid, the antibacterial activity is enhanced, like nuclease activity (Libardo
et al., 2015). To expand the utility of metal binding domain in AMPs, the Cu-ATCUN-OV-3 (OV-3; ovis-
pirin-3 from the cathelicidin family) derivative shows higher rate of antimicrobial activity toward wide range
of bacteria relative to OV-3 alone. This derivative also shows the high level of membrane leakage and lipid
peroxidation with respect to Cu-GGH or OV-3 alone. These results suggest that the Cu-GGH-OV-3 deriv-




Reviewpermeabilization of cell membrane without lipid oxidation (Alexander et al., 2017). The other AMP, Sub5 is
a linear synthetic peptide of bactenecin, which shows a broad range of antimicrobial activity against
microbes (Mania et al., 2010). Similarly, Sub5 (RRWKIVVIRWRR-NH2) lacks the metal binding domain,
ATCUN motif. Therefore, the addition of Cu-ATCUN motifs (GGH and GGHG) into Sub5 yield
Cu-GGHRRWKIVVIRWRR-NH2 and Cu-GGHGRRWKIVVIRWRR-NH2 derivatives that significantly enhance
(16 fold) the antimicrobial activity relative to parental Sub5 (Alexander et al., 2019).
Overall, the introduction of the M-ATCUN motif into AMP enhances the antimicrobial activity for a wide
range of microbes relative to AMP alone. Therefore, M-ATCUN-AMP can be considered as a potential
next-generation antibiotic for clinical treatments.
Modification of Amino Acid Residues
The redox-active amino acid residues, such as Met, Cys, His, Tyr, and Trp, are involved in different biological
redox processes (Liu et al., 2014) that include (i) deleterious phenomena, as the one occurring under oxidative
stress conditions, where the amino acids oxidation couldmodify (damage) the protein biological function (Stadt-
man 1993), and secondly, useful functions, as exemplified by stable or transient tyrosine radical or modified tyro-
sine radicals that are important for ribonucleotide reductase (Barlow et al., 1983), photosystem (Haumann et al.,
1999), cytochrome c oxidase (Yu et al., 2012), and protein-protein cross-linkage (Zhang et al., 2016) and (ii) nitra-
tion of tyrosine residues in proteins represents a specific footprint of the formation of reactive nitrogen species
(RNS) in vivo (Radi 2013). However, above discussion described that Ni-ATCUN derivatives are actively cleavage
the DNA/RNA throughNiII/NiIII redox couple. This redox chemistry of Ni-ATCUNderivative has been applied to
other performances including protein-protein cross-linking (intermolecular tyrosine-tyrosine cross-linking) (Hor-
owitz et al., 2012) and tyrosine nitration (Maiti et al., 2019).
Protein-Protein Cross-Linking. Theprotein-protein cross-linking is a usefulmethod to study for probing the
multi-protein architectures, including RNase (Gill et al., 1997), bacteriophage Qb (Meunier et al., 2004), adeno-
associated viral (AAV) capsids (Horowitz et al., 2012; Campbell et al., 1998; Fancy and Kodadek, 1999). This type
of cross-linking process has been also employed in many fields such as biochemical and biomedical research,
food processing, tissue engineering (Meunier et al., 2004; Brown et al., 1995). One usefulmethod of cross-linking
is oxidation of tyrosine residues to yield di-tyrosine product. Oxidative tyrosine cross-linking is catalyzed by
various metalloenzymes (Michon et al., 1997; Sánchez-Ferrer et al., 1995) or metal-binding peptides (Gill
et al., 1997; Brown et al., 1995; Fancy and Kodadek, 1998). For example, Ni-ATCUNwith oxidant is a useful pro-
tein cross-linking reagent for the study of macromolecular protein assemblies. Brown et al. reported a useful
cross-linking reagent, Ni-GGH and MMPP (monoperoxyphthalic acid) that efficiently produced protein-protein
cross-linking product, Tyr-Tyr unit through tyrosyl radical pathway (Brown et al., 1995). To expand the usage of
this reagent, Ni-GGH is fused with ecotin protein, yielding Ni-GGH-ecotin that oxidatively produces cross-link-
ing product, homodimeric-ecotin as serine protease inhibitor, and it is found in the periplasm of E. coli (Chung
et al., 1983;McGrath et al., 1991). To confirm the formation of bityrosyl cross-linking product, Person et al. used a
model protein, mutage GGH-ecotin (D137Y) that enhanced the 4-fold cross-linking product formation in com-
parisonwith wild-type (Person et al., 2001). TheNi-GGH catalytic site in ecotin (ecotin-A) oxidizes the close prox-
imity Tyr127 to yield tyrosine radical that finally reacts with close proximity engineered Tyr137 residue of another
ecotin (ecotin-B) molecule to yield cross-linking product, ecotin-A-Tyr127-Tyr137-ecotin-B (Figure 21).
This tyrosine-tyrosine stitching reagent is also effectively used to investigate the structure of virus system
where inter-subunit of virus is covalently stitched by the oxidation of adjacent tyrosine residues exclusively
(Meunier et al., 2004). The utility of tyrosine cross-linking is expanded toward viral capsid for structural anal-
ysis of AAV during infection. Tyr-cross-linked modified AAV showed lower transduction efficiency
compared to unmodified capsids (Horowitz et al., 2012). In addition, tyrosine-cross linking product is
also found in insulin (Correia et al., 2012). This versatility of di-tyrosine cross-linking reagent is a useful
candidate in the development of new biomaterial production for potential implication in medical research
in coming years (Kodadek 2002; Petrik 2001; MacBeath and Schreiber, 2000).
Tyrosine Nitration. The formation of 3-nitrotyrosine in vivo represents a specific footprint of RNS that is
often related to several pathophysiological disorders, such as Alzheimer’s and Parkinson’s diseases (Reyes
et al., 2011). The 3-nitrotyrosine is formed in multiple pathways involving variable RNS such as peroxynitrite
(ONOO) or nitrogen dioxide (,NO2) and promoted by transition metal ions (Fe, Cu, and Mn) or metallo-
proteins (Ferrer-Sueta et al., 2018). Very recently, Maiti et al. have presented an alternative sulfuriScience 23, 101792, December 18, 2020 27
Figure 21. The Formation of Tyrosine Cross-Linking Product by Ni-ATCUN in GGH-Ecotin (D137Y)
The ecotin structure is derived from the PBD: 1ECZ (Shin et al., 1996). The Ni-ATCUN (red star) is assumed to bind N-
terminus (green circle) of ecotin-A (gray) and distance from Tyr127 is ~11 Å. The distance between mutant Asp137/Tyr137




Reviewmetabolism pathway formation of 3-nitrotyrosine, where NiII-ATCUNmotif is conjugated with ORP to yield
NiII-ATCUN-ORP that catalyzes the nitration of tyrosine residue in ORP in the presence of nitrite and sulfite
in vitro under biological conditions (Figure 22) (Maiti et al., 2019). To our knowledge, the 3-nitrotyrosineFigure 22. Nitration of Tyrosine in ORP by Ni-ATCUN in Presence of Na2SO3/NaNO2/O2 (Modified from Maiti
et al., 2019)
The drawing was adapted from the crystal structure of apo-ATCUN-ORP [PDB: 2wfb, Najmudin et al., 2009].




Reviewformation by NiII-ATCUN in the presence of the NO2
-/SO3
2/O2 system over peroxynitrite or H2O2/NO2
system is the first report. This study represents an alternative pathway formation of 3-nitrotyrosine, which
may influence the progression of disease states in vivo involving sulfur metabolism.
Small Molecule Activation
Currently, more attention is given on small molecules activation for current sustainability issues (Meyer and
Tolman, 2015; Gutsulyak et al., 2013; Hong et al., 2017). Nature is the master of small molecule activation
and designs variety of machines such as nitrogen fixation (Hoffman et al., 2014), and photosynthesis (Yano
and Yachandra, 2014), involving one-, two-, or multi-electrons and -protons process. Every transformation
has great significance for sustainable energy. Inspired by nature, Chemists have designed peptide-based-
metal catalysts that are an emerging catalyst for small molecule activation (Yu et al., 2014; Jones et al.,
2007). The redox active M-ATCUN derivatives are primarily studied on biomolecules cleavage/modifica-
tion. These catalytic systems also serve as small molecule activations, which include water oxidation,
hydrogen evolution, and nitrite to ammonium (see below).
Water Oxidation. Water oxidation is a thermodynamically unfavorable chemical process, where oxygen
evolution from water involves the loss of four protons and four electrons (2H2O = O2 + 4H
+ + 4e, E0 =
1.23 V vs. NHE). This challenging chemical process is performed by the Nature, known as the terminal
step of photosystem II (PSII) (Hurst 2010; Liu and Wang, 2012; McEvoy and Brudvig, 2006). The interest is
basically on the formation of protons and electrons (production of H2 energy) instead of oxygen evolution,
which has been considered as the water splitting process. In this field, the designed various metal-com-
plexes such as peptide based metal complexes have progressed rapidly. For instance, Meyer et al. have
reported a Cu-peptide complex (Cu-GGGG; non-ATCUN motif), a square-based with coordinated four
N donor ligand like Cu-ATCUN system, which shows good water oxidation by electrochemically with turn-
over frequency, 33 s1 but operates at high pH  11 and high oxidation potential at 1.32 V vs. NHE (Zhang
et al., 2013).
Switching to Cu-ATCUN, water oxidation is also observed. Malinka et al. reported two mononuclear CuII
complexes with Dap-based peptides, G(Dap)GG-NH2 (3G) and G(Dap)GH-NH2 (2GH) (Dap = L-2,3-diami-
nopropionic acid) that catalyzed water oxidation. In these derivatives, the 2GH facilitates more proton-
coupled electrons transfer (PCETs) over 3G derivative in the course of water oxidation, and also improves
the turn over frequency (TOF), 53 s1 (23 s1 for 3G) at pH 11 with redox potential at 1.32 V vs. NHE. This
PCETs reaction is facilitated by the presence of His residue (Pap et al., 2015; Szyrwiel et al., 2017). Deng
et al. reported a series of ATCUN motifs, including neutral as well as positively or negatively charged
tri-peptides (GGH, KGH, RTH, DAH), tetra-peptides (GGHG, KGHG, RTHD, DAHF), and C-terminally ami-
nated tripeptides (GGH-NH2, KGH-NH2) for water oxidation. Interestingly, Cu
II-tripeptide derivatives
exhibit higher TOF for water oxidation than Cu-tetrapeptide, as well as aminated tripeptides derivatives.
Unlike other CuII-peptide derivatives, the Cu-ATCUN derivatives operate water oxidation at neutral pH and
at lower oxidation potential (Szyrwiel et al., 2017).
Hydrogen Evolution. Nature utilizes an efficient enzyme, Hydrogenases, that cleave heterolytically the
hydrogen molecule in a reversible mode (Maiti et al., 2017a; Lubitz et al., 2014). H2 production (an alterna-
tive source of fossil fuel) from the reduction of aqueous proton is one of the potential sustainable energy
routes. Numerousmetal-complexes as well as peptide-basedmetal complexes are reported for H2 produc-
tion. Among them, the most promising artificial catalysts of hydrogen evolution are mainly cobalt com-
plexes, which exhibit high turnover numbers (TONs), 5 3 104 (Sun et al., 2011; Kleingardner et al.,
2014; Eckenhoff et al., 2013).
Surprisingly, water-soluble Co-ATCUN represents a new class of hydrogen evolution catalyst and has a
similar coordination environment as reported Co-catalysts. Bren et al. reported a small Co-tripeptide
model (Co-GGH) complex that produced H2 from proton with 275 TON at nearly neutral pH and at
600 mV overpotential (Kandemir et al., 2016). This overpotential value is relatively lower than other wa-
ter-soluble cobalt porphyrin-peptide (850 mV) at pH 7 (Kleingardner et al., 2014) but higher than the pop-
ular H2 evolution Co-catalyst, ‘‘cobaloxime’’, which has lower over-potential (250–300 mV) at nearly
neutral pH (Jacques et al., 2009; Bacchi et al., 2014). This interesting feature of Co-GGH derivative is
observed due to the presence of adjacent terminal amino group to Co-center, which plays as a proton shut-




Reviewoverpotential. So, this pKa value can be modulated by modification of ATCUN peptide (Neupane et al.,
2013, 2014). At pH 6.5, the hydrogen evolution by Co-GGH derivative is higher, but the stability of the com-
plex is lower, which influences the activity. Recently, Bren et al. have also reported a light-driven reaction,
where a CoGGHderivative produces hydrogen from aqueous protons in water at near neutral pH by using a
photosensitizer ([Ru(bpy)3]
2+) and an electron donor candidate (ascorbate) (Chakraborty et al., 2019). The
turnover number of hydrogen production is up to 2200 than previous system and this catalyst also shows
exceptional longevity (more than 48 hr).
In this regard, the modification of GGH peptide in Co-GGH can be an attractive and promising hydrogen
evolution candidate that may hold the current energy issues.
Reduction of Nitrite to Ammonium. The reduction of nitrite to ammonium is a multi-electron andmulti-
proton chemical task (Rosca et al., 2009). The six electrons reduction of nitrite to ammonium is one of the
key steps in the biological nitrogen cycle that is catalyzed by cytochrome c nitrite reductase through dissim-
ilatory pathway (Einsle et al., 1999) or the siroheme-containing nitrite reductase through assimilatory
pathway (Crane et al., 1995). Important progress of bio-inspired small synthetic model systems for nitrite
reductase has been developed but most of these catalysts perform partial reduction of nitrite to nitric oxide
(1 electron game) (Timmons and Symes, 2015; Moore and Szymczak, 2015; Hematian et al., 2012) and/or
nitrous oxide (2 electrons game) (Uyeda and Peters, 2013). In 2018, Guo et al. reported a Co-GGH model
that performed selective reduction of nitrite to ammonium (six-electron and eight-proton game) by elec-
trochemically in aqueous buffer at pH 7 (Guo et al., 2018). This result indicates that a simple Co-GGH
model serves as multi-electrons and multi-protons functional activity of cytochrome c nitrite reductase
and siroheme-containing nitrite reductase (Rosca et al., 2009; Einsle et al., 1999; Crane et al., 1995). NiGGH
and CuGGH derivatives are also tested under the same conditions but none of them generates ammonia
from nitrite.
The field of small molecule activation by M-ATCUN is still in an early development stage. However, the re-
sults obtained, so far, are promising and motivating for the search of new chemical performances.CONCLUSION AND FUTURE CHALLENGES
This review aimed to shed light on wide and selective applications of designed ATCUN-derivatives
involved in multifunctional aspects such as: spectroscopic probes, sensors, target-based catalytic metallo-
drugs, biomolecules stitching, inhibition of Ab-peptide aggregation, and small molecules activation.
The redox chemistry of M-ATCUNs still rises questions but not yet fully clarified, particularly the redox cou-
ples, CuII/CuI and CuIII/CuII involved in Cu-ATCUN derivatives during production of hydroxyl radical under
ascorbate/H2O2 system. The Cu
II/CuI and CuIII/CuII redox couples with high redox potential, as well as
inherent coordination preferences by CuI and CuII make still question on redox mechanism as well as cat-
alytic efficiency. The one step progress could be the incorporation of bis-His motif nearby ATCUN (bind site
of CuI), but the problem still remains due to Cu migration from ATCUN to bis-His motif upon ascorbate
reduction that may decrease the catalytic efficiency. So, a design strategy needs to be developed, where
CuII and CuI play redox chemistry in the same framework for enhancing redox activity. The redox chemistry
of Cu-ATCUN-substrate adduct (substrate: ascorbate/H2O2/O2) can modulate the redox potential, an
aspect to be accounted.
However, the design of hybrid M-ATCUN-recognition derivatives is a useful concept for therapeutic inter-
vention. The interest is to drive the ATCUN derivatives toward cellular targets mainly cytosol and nucleus,
and these should be reached to the target position in an active form. In cellular assays, like cis-Pt (Lasorsa
et al., 2019) and TTM drug (Maiti and Moura, 2020), ATCUN drugs may also interact with intercellular pro-
teins, mainly, copper trafficking proteins such as metallothioneins (MTs; as a biological strong CuI-
chelators) and glutathione (GSH; as a biological copper reducer) (Boal and Rosenzweig, 2009). Recently,
Santoro et al. have reported that CuI and CuII oxidation states of Cu-catalysts during O2 activation under
ascorbate are unstable against GSH/MT system (Santoro et al., 2020). Therefore, intercellular Cu-trafficking
proteins are a challenge for the design of Cu-ATCUN complexes as oxidative cleavage catalysts in cells.
The other analog, Ni-ATCUN is also a promising drug but problems arise in cellular compartments due




ReviewRecent studies have shown that the novel severe acute respiratory syndrome coronavirus 2, (SARS-CoV-2)
directly binds to human ACE2 prior to entry into host cell, causing viral infection (Wrapp et al., 2020; Yan
et al., 2020; Maiti 2020). ATCUN motif can be conjugated with a recognition domain (ACE2) of SARS-
CoV-2 to yield ATCUN-recognition-domain, which can selectively bind and oxidatively modify the amino
acid residues (such as tyrosine) of spike protein and hence it would be a promising drug/therapy against
SARS-CoV-2 in future. However, more screenings are required for the development of more efficient drugs
in clinical practice.
The M-ATCUN derivatives are also employed for novel applications, which include water oxidation,
hydrogen evolution and ammonium synthesis. In these studies, the small M-ATCUN motifs (GGH) were
used wherein the second-sphere of protein scaffold was fully absent, which could enhance the catalytic ac-
tivity. This ATCUN-motif has the ability for second-sphere interactions with the metal active site via carbox-
ylate moiety or N-terminus. In the past decade, the light-driven catalytic reactions have been significantly
developing. The conjugation of photosensitizer into ATCUN motif can produce a bioinspired system that
can operate the chemical reaction by light as a renewable energy source. Recently, Bren et al. reported a
light-driven hydrogen production by using a photosensitizer ([Ru(bpy)3]
2+) (Chakraborty et al., 2019). In
addition, incorporation of redox active metal ions (such as Ru, Au, and Mn) into the designed ATCUNmotif
can perform a wide range of vital and challenging chemical transformations. Therefore, there are many
challenges in small molecule activation that can be overcome by incorporation of photosensitizer and/or
redox active metal ions into the designed ATCUN motif.
In biology, HSA possessing ATCUN site plays a key role for copper transport in human blood but the mech-
anism of copper transport and extracellular copper delivery by ATCUN tag in HSA are still unclear in vivo.
Recently, Bal et al. have demonstrated that a transient two N-coordinated Cu-ATCUN complex is formed
within very very short life time (t1/2–100 ms) during the initial stage of the interaction between Cu
II and
ATCUN site, which may be able to maintain the CuII/CuI redox couple and extracellular copper trans-
port/delivery (Kotuniak et al., 2020). As ATCUN motif has high affinity for CuII, it can recruitment CuII
ions from the labile copper pool, which has clinically significance as potential markers of copper-related
pathologies. Therefore, measurement of this labile copper pool in biological samples is a significant inter-
est. Several ATCUN-conjugate fluorescent sensors are reported, which are mainly based on turn-off CuII
sensors but the rational design of turn-on CuII sensors is still very challenging in biological medium.
Because of small size, the CuII-ATCUN is likely to introduce into protein as paramagnetic NMR tag for un-
derstanding the structure/function relationship of many biomolecules. The paramagnetic relaxation
enhancement can be improved by incorporation of lanthanoid ions such as GdIII or conjugation of GdIII che-
lates into ATCUN motif.
The redox silent (or high stable) M-ATCUN derivative is another important issue in vivo applications, such
as spectroscopic probe, bio-imaging, and copper chelation therapy. Thus, high stability and high copper
binding affinity of a designed motif can be useful for copper chelation therapy by forming a stable M-AT-
CUN derivative that significantly prevents the hydroxyl radical formation as well as Ab-peptide
aggregation.
Compared with other metal-motif, the ATCUN motif is a naturally occurring small peptide, less toxic, sol-
uble in biological buffer, and high affinity for CuII. It can be rationally designed by choice of amino acids that
can tune-up the catalytic activity and redox inertness. Furthermore, the ATCUN motif can be conjugated
with a recognition domain that provides target specificity and drug delivery, with reduced toxicity and min-
imum side effects. Bio-conjugation is not limited to the ATCUN motif. For instance, peptide is conjugated
with organometallic groups such as metallocenes (Chantson et al., 2006), hence representing another pop-
ular strategy to modulate activity and cellular uptake. However, the major challenge is intracellular delivery
to cellular targets. So, ATCUN conjugation would be a promising strategy in future. The other metal-com-
plexes such as [Fe(EDTA)]2 (EDTA = ethylenediaminetetraacetic acid) (Pogozelski et al., 1995),
[Cu(phen)2]
+ (phen = 1,10-phen-anthroline) (Sigman 1986), metalloporphyrins (Mestre et al., 1996), and
metal-salen (Czlapinski and Sheppard, 2004) are well-known metallonucleases, but in practical application,
these are less selective. Therefore, ATCUN motifs can be introduced over other metal complexes. Howev-
er, rational design is an ultimate step to overcome the critical challenges encountered in various biological
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LAQV, Fundaçaeo para a Ciência e a Tecnologia, MCTES (FCT/MCTES; UID/QUI/50006/2019).REFERENCES
Aboul-ela, F., and Varani, G. (1998). Recognition
of HIV-1 TAR RNA by tat protein and tat-derived
peptides. J. Mol. Struct. 423, 29–39.
Agbale, C.M., Cardoso, M.H., Galyuon, I.K., and
Franco, O.L. (2016). Designing metallodrugs with
nuclease and protease activity. Metallomics 8,
1159–1169.
Alexander, J.L., Yu, Z., and Cowan, J.A. (2017).
Amino terminal copper and nickel binding motif
derivatives of ovispirin-3 display increased
antimicrobial activity via lipid oxidation. J. Med.
Chem. 60, 10047–10055.
Alexander, J.L., Thompson, Z., Yu, Z., and Cowan,
J.A. (2018). Antimicrobial metallopeptides. ACS
Chem. Biol. 13, 844–853.
Alexander, J.L., Thompson, Z., Yu, Z., and Cowan,
J.A. (2019). Cu-ATCUNderivatives of Sub5 exhibit
enhanced antimicrobial activity via multiple
modes of action. ACS. Chem. Biol. 14, 449–458.
Al-Harthi, S., Lachowicz, J.I., Nowakowski, M.E.,
Jaremko, M., and Jaremko, Ł. (2019). Towards the
functional high-resolution coordination chemistry
of blood plasma human serum albumin. J. Inorg.
Biochem. 198, 110716.
Bacchi, M., Berggren, G., Niklas, J., Veinberg, E.,
Mara, M.W., Shelby, M.L., Poluektov, O.G., Chen,
L.X., Tiede, D.M., Cavazza, C., et al. (2014).
Cobaloxime-based artificial hydrogenases. Inorg.
Chem. 53, 8071–8082.
Bal, W., Chmurny, G.N., Hilton, B.D., Sadler, P.J.,
and Tucker, A. (1996). Axial hydrophobic fence in
highly-stable Ni(II) complex of des-
angiotensinogen N-terminal peptide. J. Am.
Chem. Soc. 118, 4727–4728.
Bal, W., Sokołowska, M., Kurowska, E., and Faller,
P. (2013). Binding of transition metal ions to
albumin: sites, affinities and rates. Biochim.
Biophys. Acta 1830, 5444–5455.
Bal, W., Jezowska-Bojczuk, M., and Kasprzak, K.S.
(1997). Binding of nickel(II) and copper(II) to the
N-terminal sequence of human protamine HP2.
Chem. Res. Toxicol. 10, 906–914.
Balayssac, S., Bertini, I., Bhaumik, A., Lelli, M., and
Luchinat, C. (2008). Paramagnetic shifts in solid
state NMR of proteins to elicit structural
information. Proc. Natl. Acad. Sci. USA 105,
17284–17289.
Banci, L., Bertini, I., Eltis, L.D., Felli, I.C., Kastrau,
D.H., Luchinat, C., Piccioli, M., Pierattelli, R., and
Smith, M. (1994). The three-dimensional structure
in solution of the paramagnetic high-potential
iron-sulfur protein I from Ectothiorhodospira
halophila through nuclear magnetic resonance.
Eur. J. Biochem. 225, 715–725.
Barlow, T., Eliasson, R., Platz, A., Reichard, P., and
Sjöberg, B.M. (1983). Enzymic modification of a
tyrosine residue to a stable free radical in
ribonucleotide reductase. Proc. Natl. Acad. Sci.
USA 80, 1492–1495.32 iScience 23, 101792, December 18, 2020Barthelmes, K., Reynolds, A.M., Peisach, E.,
Jonker, H.R.A., DeNunzio, N.J., Allen, K.N.,
Imperiali, B., and Schwalbe, H. (2011).
Engineering encodable lanthanide-binding tags
into loop regions of proteins. J. Am. Chem. Soc.
133, 808–819.
Battiste, J.L., Mao, H., Rao, N.S., Tan, R.,
Muhandiram, D.R., Kay, L.E., Frankel, A.D., and
Williamson, J.R. (1996). a helix-RNAmajor groove
recognition in an HIV-1 Rev peptide-RRE RNA
complex. Science 273, 1547–1551.
Bazan, J.F., and Fletterick, R.J. (1989). Detection
of a trypsin-like serine protease domain in
flaviviruses and pestiviruses. Virology 171,
637–639.
Beechem, J.M., and Brand, L. (1985). Time-
resolved fluorescence of proteins. Annu. Rev.
Biochem. 54, 43–71.
Best, S.L., Chattopadhyay, T.K., Djuran, M.I.,
Palmer, R.A., Sadler, P.J., Sóvágó, I., and Varnagy,
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